{"study_id": 47630, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine how low leucine levels in the blood affect NMEC pathogenicity and whether leucine administration could reduce bacteremia and meningitis caused by NMEC.", "results_summary": "Low leucine levels enhanced NMEC pathogenicity by downregulating NsrP, activating purine biosynthesis, and increasing bacterial survival. Intravenous leucine administration effectively reduced bacteremia and meningitis by blocking the Lrp-NsrP-PurD pathway.", "population_specificity": "Neonatal bacterial meningitis caused by Escherichia coli (NMEC) in animal models.", "effective_dosage": "Intravenous administration (specific dosage not mentioned).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:32.194716+00:00"}
{"study_id": 47631, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of short-chain fatty acids (SCFAs), particularly butyrate, on leucine uptake and protein synthesis in human skeletal muscle metabolism.", "results_summary": "Butyrate treatment increased 14C-leucine accumulation twofold, suggesting enhanced protein incorporation, while reducing its conversion into free fatty acids by more than 50%. The study found no effect of SCFAs on glucose metabolism or insulin sensitivity.", "population_specificity": "Primary human myotubes (in vitro skeletal muscle cells)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:32.733573+00:00"}
{"study_id": 47633, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the impact of short-term leucine deprivation on primary activated human T cells and its potential role in enhancing CAR-T cell efficacy.", "results_summary": "Leucine deprivation for 6 hours led to differential expression of 3,431 genes in T cells, with enrichment in TNF\u03b1 signaling, interferon-\u03b3 response, and unfolded protein response, while suppressing mTORC1 signaling, Myc targets, and oxidative phosphorylation. GCN2 kinase was found to regulate 59% of these differentially expressed genes.", "population_specificity": "Primary activated human T cells", "effective_dosage": "Not specified (leucine deprivation only)", "study_duration": "6 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:34.092454+00:00"}
{"study_id": 47632, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify potent LRRK2 inhibitors through virtual screening and molecular dynamics simulations for potential Parkinson's disease treatment.", "results_summary": "The study identified a potent LRRK2 inhibitor (compound 2) with IC50 values of 2.396 and 5.996 \u03bcM against LRRK2 and LRRK2 G2019S, respectively, demonstrating the reliability of the virtual screening approach. The compound showed favorable drug-like properties, suggesting potential for further structural optimization.", "population_specificity": "Preclinical and clinical models (not specified in detail).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:34.552582+00:00"}
{"study_id": 47634, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to review the molecular mechanisms of NLRP3 inflammasome activation and its role in inflammatory, metabolic, and neurodegenerative diseases, as well as cancer.", "results_summary": "The study summarized NLRP3 inflammasome's role in driving inflammation and pyroptosis via IL-18 and IL-1\u03b2, highlighting its potential as a therapeutic target across various diseases, including metabolic disorders and cancer.", "population_specificity": "Not specified (review article covering preclinical and clinical studies).", "effective_dosage": "Not mentioned", "study_duration": "Not applicable (review article)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:36.063077+00:00"}
{"study_id": 47636, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of LAT1/SLC7A5 in enhancing leucine's effects on protein synthesis in aging skeletal muscle and its potential implications for preventing and treating age-related sarcopenia.", "results_summary": "The study reviewed LAT1's structure and function, highlighting its role as a transmembrane transporter of leucine and its potential to enhance protein synthesis in aging skeletal muscle, suggesting new mechanisms for sarcopenia intervention.", "population_specificity": "Aging individuals with sarcopenia or age-related muscle decline.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:37.035451+00:00"}
{"study_id": 47635, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of Leucine-rich \u03b12-glycoprotein (LRG) in inflammatory bowel disease (IBD) and its mechanism involving TGF-\u03b2 signaling and leukocyte trafficking.", "results_summary": "LRG deficiency in mice reduced colitis severity, attenuated leukocyte infiltration, and suppressed endoglin upregulation in endothelial cells. Recombinant LRG enhanced TGF-\u03b21-induced endoglin expression and increased monocyte adherence to endothelial cells, suggesting LRG accelerates colonic inflammation.", "population_specificity": "Wild-type and LRG-deficient mice with DSS-induced colitis.", "effective_dosage": "Not specified (3% DSS treatment used to induce colitis).", "study_duration": "Observations made up to day 3 post-DSS treatment.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:39.202647+00:00"}
{"study_id": 47637, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the association between dietary protein supplementation (Reha-Time Jelly\u00ae) and changes in renal function (eGFR) and physical outcomes in post-stroke rehabilitation patients.", "results_summary": "The study found that nutritional supplementation (Reha-Time Jelly\u00ae) increased BMI and preserved bone mineral content but showed no significant effects on renal function, motor function, or serum markers. A trend toward improved chair stand test performance was noted in the supplemented group.", "population_specificity": "Japanese stroke patients undergoing rehabilitation (mean age 70.2 \u00b1 10.0 years, 65% male, 31.7% with chronic kidney disease).", "effective_dosage": "120 g Reha-Time Jelly\u00ae after each rehabilitation session (frequency not specified).", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:39.510382+00:00"}
{"study_id": 47639, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether serum levels of leucine-rich \u03b12-glycoprotein (LRG) are associated with cognitive impairment in Parkinson's disease patients.", "results_summary": "The study found that serum LRG levels were significantly higher in PD patients who developed cognitive impairment compared to those who did not, suggesting LRG may serve as a predictor of cognitive decline in PD. ROC analysis indicated LRG levels effectively predicted cognitive impairment occurrence.", "population_specificity": "Parkinson's disease patients without baseline cognitive impairment.", "effective_dosage": "Not specified", "study_duration": "1 year", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:40.117176+00:00"}
{"study_id": 47638, "supplement_id": 1287, "safety_score": "90", "efficacy_score": 85, "quality_score": 65, "study_goal": "The researchers aimed to determine if N-acetyl-leucine (NAL) could effectively treat CACNA1A-related disorders, focusing on improvements in ataxia, cognitive impairment, and epilepsy.", "results_summary": "NAL led to rapid and sustained improvement in ataxia (gait, balance, fine motor, and speech) with mean SARA score improvements of 3.25 points initially and 5.13 points long-term. The treatment was well-tolerated with no adverse reactions reported.", "population_specificity": "Four pediatric patients (ages 5, 9, 14, and 15) with CACNA1A-related disorders.", "effective_dosage": "Not specified", "study_duration": "Up to 3 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:40.976794+00:00"}
{"study_id": 47640, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop a method (Zip sorting) using leucine zippers to purify T cells co-transduced with multiple vectors for enhanced CAR T cell therapy.", "results_summary": "The study found that Zip sorting enabled T cells to express multiple CARs and switch receptors, effectively eliminating heterogeneous leukemia cells in mouse models and overcoming CAR T cell resistance mechanisms.", "population_specificity": "Syngeneic mouse models with leukemia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:42.608864+00:00"}
{"study_id": 47643, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether pretreatment serum leucine-rich alpha-2 glycoprotein (LRG) levels could predict the clinical effectiveness and serum trough levels of ustekinumab in patients with inflammatory bowel disease (IBD).", "results_summary": "The study found that lower pretreatment serum LRG levels were significantly associated with higher clinical remission rates and higher serum trough levels of ustekinumab at week 8, suggesting LRG as a predictive biomarker for treatment effectiveness.", "population_specificity": "184 patients with IBD (104 Crohn's disease, 80 ulcerative colitis) receiving ustekinumab or anti-tumor necrosis factor therapy.", "effective_dosage": "Not specified", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:44.777701+00:00"}
{"study_id": 47642, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to uncover the molecular mechanism by which ethylene, via the transcription factor RhHB22 (containing a leucine zipper domain), inhibits ascorbic acid biosynthesis and promotes petal senescence in roses.", "results_summary": "The study found that ethylene-induced RhHB22 suppresses RhGGP1 expression, reducing ascorbic acid production and increasing ROS accumulation, thereby accelerating petal senescence. Silencing RhHB22 delayed senescence by restoring RhGGP1 expression and ascorbic acid levels.", "population_specificity": "Rose petals (plant model, not human).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:44.922041+00:00"}
{"study_id": 47644, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to investigate the role of leucine-rich repeat kinase 2 (LRRK2) in nonsmall cell lung cancer (NSCLC) and its interaction with circ_0004630 and miR-1208.", "results_summary": "The study found that circ_0004630 and LRRK2 were upregulated in NSCLC tissues and cells, while miR-1208 was downregulated. Downregulation of circ_0004630 inhibited NSCLC cell proliferation, invasion, glycolysis, and promoted apoptosis, suggesting a potential role of the miR-1208/LRRK2 axis in NSCLC progression.", "population_specificity": "NSCLC tissues and cells (in vitro and in vivo xenograft tumor model).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:45.822608+00:00"}
{"study_id": 47645, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate how leucine deprivation affects ribosomal stalling, aberrant protein production, and potential implications for anti-cancer therapy.", "results_summary": "Leucine deprivation led to ribosomal stalling and aberrant protein production, particularly at the UUA codon, in various cancer cell types. These aberrant proteins could be processed into neoepitopes, triggering T-cell killing, suggesting a potential mechanism for anti-cancer therapy.", "population_specificity": "Cancer cell types (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:46.839084+00:00"}
{"study_id": 47647, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine if salivary leucine-rich \u03b12 glycoprotein (LRG) levels correlate with the severity of periodontitis and if initial periodontal therapy (IPT) affects these levels.", "results_summary": "Salivary LRG levels were higher in patients with severe periodontitis compared to mild cases and significantly decreased after IPT. LRG levels positively correlated with clinical periodontal parameters like probing depth and bleeding on probing.", "population_specificity": "63 patients with chronic periodontitis (30 with Stage III, Grade B or C; 33 with Stage I or II, Grade A).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:48.449240+00:00"}
{"study_id": 47646, "supplement_id": 1287, "safety_score": "30", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine how elevated leucine levels affect cardiac microvascular endothelial cells and contribute to congenital heart defects (CHDs) via the WDPCP/MAPK signaling axis.", "results_summary": "High leucine levels were associated with reduced WDPCP expression and impaired MAPK/ERK signaling, leading to defective endothelial cell function. Overexpression of WDPCP or activation of MAPK rescued these effects, suggesting a potential therapeutic target.", "population_specificity": "Neonatal patients with CHDs, pregnant mice, and human cardiac microvascular endothelial cells (HCMECs).", "effective_dosage": "Not specified (high-leucine diet and treatment used).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:48.633544+00:00"}
{"study_id": 47648, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate the oncogenic roles of lncRNA LRRC75A-AS1 in renal cell carcinoma (RCC) and its potential as a prognostic biomarker.", "results_summary": "The study found that LRRC75A-AS1 was significantly upregulated in clear cell RCC tissues, associated with poor prognosis, and promoted cell proliferation and invasion in RCC cell lines. The interaction among LRRC75A-AS1, miR-370-5p, and ADAMTS5 was suggested as a regulatory mechanism underlying RCC progression.", "population_specificity": "212 patients with clear cell RCC who underwent nephrectomy.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:49.701273+00:00"}
{"study_id": 47649, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether a leucine-rich diet could reduce inflammation and improve gut health in a mouse model of inflammatory bowel disease (IBD).", "results_summary": "A leucine-rich diet transiently reduced fecal MPO levels before DSS treatment but did not significantly protect against DSS-induced colitis symptoms or long-term inflammation. No significant differences were observed in gut permeability, MPO activity, or body weight changes between leucine-supplemented and control groups after DSS treatment.", "population_specificity": "Germ-free SAMP1/YitFC mice colonized with human gut microbiota (hGF-SAMP).", "effective_dosage": "Not specified (leucine-rich diet composition details not provided).", "study_duration": "At least five weeks (prior to DSS treatment).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:52.019516+00:00"}
{"study_id": 47651, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the effects of dietary L-Leucine supplementation on amino acid composition, serum metabolism, and meat quality in beef cattle.", "results_summary": "L-Leucine supplementation improved plasma leucine bioavailability, altered amino acid concentrations, increased total protein content, and enhanced meat quality by reducing subcutaneous fat thickness and increasing crude protein content in muscle.", "population_specificity": "Twenty-four Angus cows with similar initial weight (575.5 \u00b1 22.1 kg).", "effective_dosage": "6.0 g/100 kg body weight per day.", "study_duration": "120 days pre-slaughter.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:53.143135+00:00"}
{"study_id": 47652, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the structure, function, molecular mechanisms, and inhibitors of LRPPRC, focusing on its role in cancer progression and potential as a therapeutic target.", "results_summary": "The study found that LRPPRC expression is elevated in most cancer types and predicts poor prognosis. Targeting LRPPRC suppresses tumor progression by affecting cancer hallmarks such as signal transduction, metabolism, and immune regulation.", "population_specificity": "Not specified (general focus on cancer research).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:53.227571+00:00"}
{"study_id": 47650, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine how mechanical loading from different exercise modalities affects GILZ and atrogene expression in skeletal muscle, particularly in the context of statin-associated muscle symptoms.", "results_summary": "Resistance training (RT) resulted in the highest suppression of GILZ, significantly differing from endurance training (END) but not from eccentric resistance training (ECC). Similar patterns were observed for various atrogenes, suggesting mechanical loading is a key mediator of exercise-induced changes in these markers.", "population_specificity": "204 participants (22 females; 182 males) from 15 studies.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Statin treatment was noted to interact with exercise modalities in regulating GILZ and atrogene expression.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:54.023005+00:00"}
{"study_id": 47653, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to analyze LRG levels as a biomarker for mucosal healing in ulcerative colitis patients treated with molecular-targeted drugs, assessing variations by clinical characteristics and drug type.", "results_summary": "The study found that LRG levels were significantly higher in women and older patients, and varied by drug type, with vedolizumab associated with higher levels and JAK inhibitors with lower levels.", "population_specificity": "111 patients with ulcerative colitis who achieved mucosal healing and were treated with biologics or JAK inhibitors.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:54.490318+00:00"}
{"study_id": 47655, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the effects of glucocorticoid-induced leucine zipper protein (GILZp) and a yeast extract (Py) on colitis, focusing on their potential to alleviate inflammation and restore fungal dysbiosis.", "results_summary": "Both GILZp and Py reduced pro-inflammatory cytokines (IL-1\u03b2, TNF-\u03b1) and improved gut barrier function by modulating tight junction proteins. They also restored intestinal fungal balance, particularly reducing Meyerozima genus abundance in colitic mice.", "population_specificity": "DSS-induced colitis mice model.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:57.034578+00:00"}
{"study_id": 47656, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine leucine's role in mitigating the virulence of A. baumannii and its potential as a therapeutic intervention.", "results_summary": "Leucine was identified as a key biomarker that reduced A. baumannii virulence by modulating mitochondrial dysfunction and oxidative stress, leading to decreased pathogenicity in Beas 2B cells, G. mellonella, and mice lung tissues.", "population_specificity": "In vitro (Beas 2B cells), in vivo (G. mellonella and mice)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:57.287566+00:00"}
{"study_id": 47654, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to assess leucine intake and its association with sarcopenia indicators in elderly Chilean adults participating in a food assistance program.", "results_summary": "The study found that 78.45% of participants did not meet the recommended leucine intake (3 g/day), and sarcopenia was identified in 17.13% of them. No significant differences in muscle strength or mass were observed between those with adequate and inadequate leucine intake, and PACAM food consumption did not notably improve these parameters.", "population_specificity": "181 adults aged 60-80 in Santiago, Chile (80% women) participating in the Program for Complementary Food in Older People (PACAM).", "effective_dosage": "Recommended intake of 3 g per day (though actual intake was not specified for all participants).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:57.567170+00:00"}
{"study_id": 47657, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to identify how leucine-rich alpha-2-glycoprotein 1 (LRG1) activates HER3 in colorectal cancer (CRC) and explore its role in promoting liver metastasis.", "results_summary": "The study found that LRG1 directly binds and activates HER3, promoting CRC growth independently of neuregulin. Blocking LRG1 impaired liver metastasis and prolonged survival in murine models, identifying a novel therapeutic pathway.", "population_specificity": "Preclinical models (murine) and patient-derived primary liver endothelial cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:59.754927+00:00"}
{"study_id": 47658, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether dietary restriction of leucine could reduce intratumoral Fusobacterium nucleatum (Fn) load and resensitize nasopharyngeal carcinoma (NPC) tumors to radiotherapy.", "results_summary": "The study found that Fn promotes radioresistance in NPC by inhibiting PANoptosis via the SLC7A5/leucine-mTORC1 axis. Dietary restriction of leucine reduced Fn load and improved tumor sensitivity to radiotherapy in vivo.", "population_specificity": "Patients with nasopharyngeal carcinoma (NPC).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:00.897117+00:00"}
{"study_id": 47660, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to report a case of anti-LGI1 encephalitis presenting with ictal pouting and assess the response to steroid treatment.", "results_summary": "Steroid treatment resolved seizures and improved subtle visual memory in a patient with anti-LGI1 encephalitis presenting with ictal pouting. The study suggests thorough evaluation for memory disturbances in middle-aged and older patients with subacute-onset focal seizures to identify anti-LGI1 encephalitis.", "population_specificity": "A 73-year-old man with anti-LGI1 encephalitis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:01.263149+00:00"}
{"study_id": 47659, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the diagnostic and prognostic potential of Fetuin-A and LRG1 in patients with prostate cancer, not Leucine.", "results_summary": "The study found significantly higher Fetuin-A levels in prostate cancer patients compared to controls without malignancy, but no significant difference in LRG1 levels between groups. Higher LRG1 levels were observed in metastatic (M1) patients compared to non-metastatic (M0) patients, though the difference was borderline significant.", "population_specificity": "Patients with prostate cancer (n=46), young healthy subjects (n=26), and patients with negative prostate biopsy (n=46).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:02.036462+00:00"}
{"study_id": 47661, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether embryonic leucine supplementation influences growth and gene expression in Japanese quails via the IGF-1/mTOR pathway.", "results_summary": "Leucine-treated quails showed increased post-hatching growth in body mass and multiple anatomical measurements, along with upregulated hepatic expression of IGF1, IGF1R, mTOR, and RPS6K1, while FOXO1 expression remained unchanged.", "population_specificity": "Japanese quail embryos and post-hatching chicks", "effective_dosage": "2.5 mg leucine injected once on the tenth day of incubation", "study_duration": "Single administration, effects observed up to 21 days post-hatching", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:02.969896+00:00"}
{"study_id": 47666, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to elucidate the molecular mechanism by which leucine, via BCAT1-mediated catabolism, regulates immune responses, particularly Th17 and IL-17 production.", "results_summary": "The study found that leucine catabolism via BCAT1 generates HMB, which regulates the mTORC1-HIF1\u03b1 pathway, enhancing IL-17 production in activated CD4+ T cells; inhibition of this pathway reduced IL-17 production and mitigated EAE severity in vivo.", "population_specificity": "Human CD4+ T cells and an in vivo experimental autoimmune encephalomyelitis (EAE) mouse model.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:05.224104+00:00"}
{"study_id": 47664, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to determine whether acetyl-DL-leucine (ADLL) could modify disease progression in prodromal Parkinson's disease (PD) in patients with isolated REM sleep behavior disorder (iRBD).", "results_summary": "ADLL treatment (5 g/d) led to a marked reduction in RBD severity scores in both patients, with improvements in dopamine-transporter binding ratios and stabilization or reduction in metabolic PD-related pattern scores over 18-22 months.", "population_specificity": "Two patients (one female, one male) with isolated REM sleep behavior disorder (iRBD), a prodromal stage of Parkinson's disease.", "effective_dosage": "5 g/d", "study_duration": "18-22 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:06.160858+00:00"}
{"study_id": 47667, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether quinoa protein hydrolysate (QPH), particularly the peptide QPH-FR, could enhance chemosensitivity in colorectal cancer by targeting LGR5 and suppressing the Wnt/\u03b2-catenin signaling pathway.", "results_summary": "QPH reduced tumor volume in the 5-FU+QPH group compared to the 5-FU group, indicating enhanced chemosensitivity. The peptide QPH-FR competitively inhibited the LGR5/RSPO1 complex, suppressed Wnt/\u03b2-catenin signaling, and exerted stemness inhibition.", "population_specificity": "Colorectal cancer (CRC) models (in vivo).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:06.545984+00:00"}
{"study_id": 47668, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the role of MELK in Burkitt lymphoma treatment and develop a PROTAC (MGP-39) targeting MELK for improved anti-cancer activity and reduced toxicity.", "results_summary": "The study found that MGP-39, a MELK-targeting PROTAC, effectively degraded MELK in RAMOS cells, induced cell cycle arrest and apoptosis, and demonstrated superior anti-cancer activity and lower toxicity compared to traditional MELK inhibitors.", "population_specificity": "Burkitt lymphoma (RAMOS cells, a B-cell malignancy model)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:07.537942+00:00"}
{"study_id": 47669, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to highlight the diagnostic challenges and clinical presentation of anti-LGI1 limbic encephalitis (anti-LGI1 LE) to improve early recognition and treatment.", "results_summary": "The study presented a case of anti-LGI1 LE with a delayed diagnosis due to misleading psychiatric symptoms and inconsistent MRI findings, emphasizing the need for thorough clinical evaluation and awareness of autoimmune encephalitis presentations.", "population_specificity": "A patient with a history of psychiatric issues, aberrant spasms, and encephalopathy, eventually diagnosed with anti-LGI1 LE.", "effective_dosage": "Not mentioned", "study_duration": "Symptoms emerged over two years.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:09.281175+00:00"}
{"study_id": 47670, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effect of protein persulfidation, specifically on leucine aminopeptidase (LAP) activity, in pepper fruits during ripening.", "results_summary": "Persulfidation increased LAP activity by 3-fold, an effect reversible with dithiothreitol (DTT). The study suggests LAP may play a role in glutathione (GSH) recycling in pepper fruits.", "population_specificity": "Sweet pepper (Capsicum annuum L.) fruits at immature green and ripe red stages.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:09.405745+00:00"}
{"study_id": 47671, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 45, "study_goal": "The researchers aimed to characterize pediatric cases of LGI-1 encephalitis, comparing them to adult cases, and evaluate diagnostic and treatment approaches.", "results_summary": "The study found that pediatric LGI-1 encephalitis presents with neuropsychiatric symptoms and refractory focal seizures, differing from adult cases. Diagnosis was confirmed via serum antibody testing, and treatment with immunotherapy and antiseizure medications improved symptoms.", "population_specificity": "Pediatric patients with LGI-1 encephalitis (two cases reviewed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:09.630263+00:00"}
{"study_id": 47672, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to explore the immunomodulatory effects of glucocorticoid-induced leucine zipper (GILZ) in macrophages, focusing on its role in inflammatory response, phagocytosis, cell death, and mitochondrial function.", "results_summary": "GILZ overexpression enhanced phagocytic and antibacterial activity, reduced pyroptotic cell death, and decreased mitochondrial respiration while increasing matrix metalloproteinase activity, suggesting its role in tissue remodeling and potential as a therapeutic target for inflammatory disorders.", "population_specificity": "Macrophages (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:10.508745+00:00"}
{"study_id": 47673, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine whether nutritional guidance focused on leucine intake could improve plasma leucine concentrations, lean body mass, and muscle strength in patients undergoing maintenance cardiac rehabilitation.", "results_summary": "The study found that leucine-focused nutritional guidance significantly increased protein and estimated leucine intake, leading to higher lean body mass in the intervention group. Plasma leucine concentration changes positively correlated with lean body mass and grip strength improvements in the intervention group.", "population_specificity": "Patients undergoing maintenance cardiac rehabilitation (intervention group: 53.2\u00b118.2 years; control group: 58.6\u00b115.3 years).", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:15.055270+00:00"}
{"study_id": 47675, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the role of FBXL6 (a leucine-rich repeat protein) in glioma progression, its prognostic value, and potential as a therapeutic target.", "results_summary": "The study found that FBXL6 expression strongly correlates with glioma progression, tumor-infiltrating immune cells, and drug sensitivity, suggesting its potential as a diagnostic and prognostic marker.", "population_specificity": "Patients with gliomas (data sourced from The Cancer Genome Atlas and Chinese Glioma Genome Atlas databases).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:15.214663+00:00"}
{"study_id": 47674, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate whether Leucine-rich \u03b1-2-glycoprotein (LRG) could serve as an early-phase biomarker for predicting clinical and endoscopic response to induction therapy in ulcerative colitis (UC) patients.", "results_summary": "LRG and CRP at week 1 were significantly lower in patients achieving clinical remission, with LRG showing predictive value for both clinical remission at week 8 and subsequent endoscopic improvement within 1 year, outperforming fecal calprotectin (FC) in early-phase prediction.", "population_specificity": "143 patients with ulcerative colitis initiating induction therapy with steroids or advanced therapies (biologics or Janus kinase inhibitors).", "effective_dosage": "Not specified", "study_duration": "Assessments at baseline, week 1, and week 8, with endoscopic follow-up within 1 year.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:15.603964+00:00"}
{"study_id": 47677, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether the synthetic peptide TAT-GILZ, derived from glucocorticoid-induced leucine zipper (GILZ), could promote hair growth in mice.", "results_summary": "TAT-GILZ accelerated hair growth in depilated BALB/c mice and induced hair growth in athymic mice, where hair growth was unexpected. It also enhanced hair follicle stem cells and re-established homeostasis by increasing anti-inflammatory signals.", "population_specificity": "9-12 week-old male BALB/c and nude (athymic, nu/J) mice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:15.607339+00:00"}
{"study_id": 47679, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to synthesize and characterize a novel L-leucine-based poly(diacylhydrazine) polymer for its thermal stability and on-demand degradability.", "results_summary": "The study successfully synthesized a thermally and chemically stable poly(diacylhydrazine) polymer from L-leucine methyl ester, which rapidly degrades upon exposure to sodium hypochlorite, yielding monomeric carboxylic acid and nitrogen gas. The polymer exhibited high thermal stability (10% weight loss at 286\u00b0C) and no oxidation by oxygen.", "population_specificity": "Not applicable (in vitro chemical synthesis study).", "effective_dosage": "Not applicable.", "study_duration": "Not applicable.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:17.991164+00:00"}
{"study_id": 47681, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the role of LRPPRC in regulating the JAK2/STAT3/MYC axis and its potential as a therapeutic target in esophageal squamous cell carcinoma (ESCC).", "results_summary": "The study found that LRPPRC facilitates JAK2/STAT3/MYC axis activation by impairing m6A modification and enhancing complex stability, promoting ESCC progression. A compound (5,7,4'-trimethoxyflavone) targeting LRPPRC, STAT3, and CDK1 disrupted these interactions, suppressing tumor growth in mouse models.", "population_specificity": "ESCC mouse models and patient-derived xenograft mouse models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:19.204735+00:00"}
{"study_id": 47680, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of Microcystin-leucine arginine (MC-LR) on the progression of cholangiocarcinoma (CCA) via the Wnt/\u03b2-catenin pathway in vitro.", "results_summary": "MC-LR enhanced cell division, migration, and S phase progression in cholangiocyte and CCA cell lines, activating the Wnt/\u03b2-catenin pathway and upregulating \u03b2-catenin and its downstream targets. \u03b2-catenin expression was significantly higher in cancerous tissue compared to adjacent areas.", "population_specificity": "Human immortalized cholangiocyte cells (MMNK-1) and a human cell line established from opisthorchiasis-associated CCA (KKU-213B).", "effective_dosage": "1, 10, 100, and 1,000 nM of MC-LR.", "study_duration": "24-hour treatment.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:19.654038+00:00"}
{"study_id": 47682, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to determine whether resistance exercise with leucine-enriched essential amino acid (LEAA) supplementation prevents muscle mass loss in post-gastrectomy patients.", "results_summary": "The study found no significant difference in muscle mass between the intervention and control groups, but the intervention group showed significant improvements in muscle strength and quality of life (QOL).", "population_specificity": "Post-gastrectomy gastric cancer patients", "effective_dosage": "3 g of LEAA twice daily", "study_duration": "15 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:22.435480+00:00"}
{"study_id": 47683, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the potential of leucine aminopeptidase (LAP) as a biomarker for liver cancer diagnosis and prognosis, and to assess the effectiveness of a novel near-infrared fluorescent probe (NTAP) for LAP detection.", "results_summary": "The study demonstrated that the NTAP probe effectively detected LAP activity with high sensitivity (LOD 0.0038 U/mL) and selectivity, enabling accurate imaging of metastatic lesions in animal models. The probe showed stability and specificity in complex samples and cellular environments.", "population_specificity": "Animal models of liver and lung metastasis.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:23.597409+00:00"}
{"study_id": 47685, "supplement_id": 1287, "safety_score": "85", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to assess the efficacy of N-acetyl-l-leucine (NALL) in improving motor function and quality of life in patients with Ataxia Telangiectasia (AT).", "results_summary": "NALL treatment did not significantly improve ataxia symptoms or motor function but alleviated nausea and constipation. No serious or moderate side effects were reported.", "population_specificity": "16 patients (8 females, 8 males; mean age 9.8 \u00b1 3.5 years) with a definitive genetic diagnosis of AT.", "effective_dosage": "1-4 g/day", "study_duration": "Six weeks per treatment phase, with a 4-week washout between phases.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:25.391667+00:00"}
{"study_id": 47687, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop biosensors using leucine-functionalized gold and silver nanoparticles for disease detection and drug delivery in precision medicine.", "results_summary": "The study successfully synthesized stable, monodisperse nanoparticles coated with leucine-derived dipeptides, demonstrating their potential as biomarker sensors and drug-delivery platforms. The dipeptide arrangement on the nanoparticles' surface was controllable, enabling effective interaction with biological environments.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:25.693961+00:00"}
{"study_id": 47686, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether serum LRG1 levels could serve as a diagnostic marker to differentiate clear cell renal cell carcinoma (ccRCC) from non-ccRCC and non-cancer patients.", "results_summary": "The study found that serum LRG1 levels were significantly higher in ccRCC patients compared to non-ccRCC and non-cancer patients, with excellent diagnostic accuracy (AUC 0.91 for differentiating ccRCC from non-ccRCC). LRG1 was also associated with inflammation and malignant potential in ccRCC.", "population_specificity": "64 patients with ccRCC, 22 with non-ccRCC, and 63 non-cancer patients who underwent radical or partial nephrectomy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:25.695304+00:00"}
{"study_id": 47688, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of Leucine Rich Repeat-Malectin (LRR-MAL) receptor kinases in plant immune responses to carbohydrate-based DAMPs/MAMPs.", "results_summary": "The study found that IGP1/CORK1, IGP3, and IGP4 LRR-MAL RKs are required for the perception of carbohydrate-based DAMPs like XYL4 and XA3XX, expanding their known function in plant glycan perception and immune activation.", "population_specificity": "Arabidopsis thaliana seedlings and other plant species (tomato, wheat).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:27.129019+00:00"}
{"study_id": 47689, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to understand the role of Dual-leucine Zipper Kinase (DLK) in mediating neuronal cytoskeletal homeostasis and the Cytoskeletal Stress Response (CSR) pathway.", "results_summary": "The study found that low-dose nocodazole treatment activates DLK signaling, leading to a DLK-dependent transcriptional signature that includes genes regulating actin and attenuating DLK signaling, resulting in cytoskeletal alterations and axon morphological changes.", "population_specificity": "Neurons (in vitro or animal model, not specified in abstract)", "effective_dosage": "Low-dose nocodazole (specific amount not provided)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:28.432410+00:00"}
{"study_id": 47691, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether the combination of l-arginine and l-leucine improves blastocyst implantation ability in IVF-derived mouse blastocysts.", "results_summary": "The combination of l-arginine and l-leucine increased blastocyst implantation by elevating ROS levels and integrin \u03b15\u03b21 expression, while l-arginine alone reduced implantation ability and increased apoptosis.", "population_specificity": "IVF-derived mouse blastocysts", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:31.748278+00:00"}
{"study_id": 47690, "supplement_id": 1287, "safety_score": "70", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the toxicity, antiproliferative, proapoptotic, and antimigratory effects of Fmoc-L-Leucine (FL), a PPAR\u03b3 agonist, alone and in combination with celecoxib (CXB) on temozolomide-resistant glioma cells and normal cells.", "results_summary": "FL demonstrated effective antiproliferative, pro-apoptotic, and anti-migratory effects on U-118 MG glioma cells at 50-100 \u00b5M, but lacked selectivity for glioma cells over normal cells. No synergistic effect with CXB was observed, and HaCaT keratinocytes were resistant to FL.", "population_specificity": "Temozolomide-resistant U-118 MG glioma cells, BJ normal fibroblasts, immortalized HaCaT keratinocytes, and C. elegans nematodes.", "effective_dosage": "50-100 \u00b5M", "study_duration": "Up to 7 days (in vivo C. elegans study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:33.563641+00:00"}
{"study_id": 47695, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to computationally evaluate LRRK2 G2019S inhibitors as potential therapeutic targets for Parkinson's disease using a multi-step screening and modeling approach.", "results_summary": "The study employed similarity and pharmacophore screening, structure-based affinity prediction, molecular docking, and rescoring to identify potential inhibitors. MD simulations and MM/GBSA calculations validated the prediction methods, and a structure-activity relationship was built using 170 experimental ligands.", "population_specificity": "Not specified (computational study)", "effective_dosage": "Not available", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:34.969575+00:00"}
{"study_id": 47693, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to identify and characterize leucine aminopeptidase (LAP) genes in pepper fruits and evaluate their role during ripening and under nitric oxide (NO) exposure.", "results_summary": "The study identified two LAP genes (CaLAP1 and CaLAP2) with differential expression during ripening (CaLAP1 decreased, CaLAP2 increased) and NO treatment (both downregulated). LAP activity increased by 81% during ripening but was inhibited by peroxynitrite and reducing agents, while cyanide upregulated it.", "population_specificity": "Pepper (Capsicum annuum L.) fruits", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:35.643377+00:00"}
{"study_id": 47694, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the role of ANP32B (an acidic leucine-rich nuclear protein) in prostate adenocarcinoma (PRAD) progression and its potential as a therapeutic marker.", "results_summary": "ANP32B was upregulated in PRAD and promoted cell proliferation, growth, and migration, while its inhibition suppressed these effects. Molecular markers linked to cell growth and migration (e.g., cyclin D1, N-cadherin) were upregulated, while inhibitory markers (e.g., cleaved caspase 3, E-cadherin) were downregulated.", "population_specificity": "Prostate adenocarcinoma (PRAD) tissues and cells (DU145 and PC3 cell lines).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:36.067161+00:00"}
{"study_id": 47696, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether leucine supplementation could improve protein synthesis defects and extend lifespan in SOD1G93A mice, a model for ALS.", "results_summary": "Leucine supplementation extended the lifespan of SOD1G93A mice, improved muscle strength, and increased the number of neuromuscular junctions, similar to the effects of VCP overexpression.", "population_specificity": "SOD1G93A mice (a model for amyotrophic lateral sclerosis).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:36.514424+00:00"}
{"study_id": 47692, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to determine the influence of leucine enkephalin (L-ENK) on the hypophysial-testicular axis and spermatogenesis in cichlid fish.", "results_summary": "A low dose of L-ENK increased spermatocyte and spermatid numbers and androgen receptor activity without altering hormone levels, while a high dose reduced spermatocyte numbers, androgen receptor activity, and hormone levels, suggesting dose-dependent effects on spermatogenesis.", "population_specificity": "Cichlid fish (Oreochromis mossambicus)", "effective_dosage": "60 \u00b5g (low dose), 200 \u00b5g (high dose)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:36.602927+00:00"}
{"study_id": 47678, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to describe a unique case of anti-LGI1 limbic encephalitis presenting with panic attacks and rhythmic facial movements, emphasizing early diagnosis and treatment.", "results_summary": "The study found that prompt recognition of symptoms and treatment with steroids, immunotherapy, and lacosamide led to significant improvement in the patient. It highlighted the importance of awareness of FBDS, cognitive disturbances, and hyponatremia for early diagnosis.", "population_specificity": "Elderly female with anti-LGI1 limbic encephalitis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:41.091611+00:00"}
{"study_id": 47697, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to characterize the clinical features and outcomes of patients with anti-LGI1 encephalitis within the first year after initial immunotherapy.", "results_summary": "The study found that unsuspected clinical and sleep abnormalities persisted in patients with anti-LGI1 encephalitis after initial immunotherapy, with cognitive deficits remaining in 65% of patients at 12 months. Additional immunotherapy improved symptoms in some patients, but persistent deficits were associated with factors like lack of rituximab use and REM sleep abnormalities.", "population_specificity": "Patients with anti-LGI1 encephalitis (mean age 63 years, 54% female) and healthy controls (mean age 62 years, 61% female) from 21 hospitals in Spain.", "effective_dosage": "Not mentioned", "study_duration": "12 months (with assessments at baseline, 6 months, and 12 months)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:41.269300+00:00"}
{"study_id": 47698, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to systematically identify and analyze HD-Zip transcription factors in Salix suchowensis to understand their structural characteristics and roles in stress response.", "results_summary": "The study identified 55 HD-Zip genes in willow, classified into four subfamilies, and found that certain genes (SsHox34, SsHox36, SsHox51) were significantly involved in responses to abiotic stresses like salt, PEG, and heat treatments. Synergistic effects between SsHD-Zip I genes under stress conditions were also observed.", "population_specificity": "Salix suchowensis (willow) plants", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:43.115192+00:00"}
{"study_id": 47699, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the regulatory mechanism of leucine on lipid metabolism in finishing pigs, focusing on its effects on growth performance, adipose tissue lipolysis, gut microbiota, and bile acid metabolism.", "results_summary": "Leucine supplementation (0.25% and 0.50%) increased average daily gain, reduced backfat thickness and feed-to-gain ratio, modulated lipid metabolism-related gene expression, enhanced gut microbiota diversity, and influenced bile acid metabolites, suggesting a role in promoting lipolysis via the mTOR-SIRT1 pathway.", "population_specificity": "Finishing pigs (Duroc \u00d7 Landrace \u00d7 Large cross) with an average body weight of 68.33 \u00b1 0.97 kg.", "effective_dosage": "0.25% and 0.50% dietary leucine.", "study_duration": "42 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:44.940559+00:00"}
{"study_id": 47701, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of Leucine zipper downregulated in cancer-1 (LDOC1) in regulating EGFR clathrin-mediated internalization and its impact on the efficacy of first-generation EGFR-TKIs in EGFR-mutated NSCLC.", "results_summary": "LDOC1 depletion promoted EGFR internalization and recycling, reduced membranous EGFR, and enhanced activation of EGFR, AXL, HER2, and HER3, leading to reduced sensitivity to EGFR-TKIs. LDOC1 downregulation was associated with poor overall survival in EGFR-mutated NSCLC patients treated with gefitinib.", "population_specificity": "Patients with EGFR-mutated non-small cell lung cancer (NSCLC) and EGFRM NSCLC cell lines (PC9 and HCC827).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:45.746253+00:00"}
{"study_id": 47702, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate how pre-heating and increased Hsp72 expression affect mTOR signaling and protein synthesis in rat gastrocnemius muscle following leucine administration.", "results_summary": "Pre-heating upregulated Hsp72 but partially blunted muscle protein synthesis signaling after leucine administration, with reduced 4E-BP1 phosphorylation in the red muscle portion and altered c-Myc expression in both red and white muscle portions.", "population_specificity": "Male Wistar rats (10-week-old, n = 23)", "effective_dosage": "Not specified", "study_duration": "Leucine administration followed a 48-hour recovery period after heat stress; muscle samples were taken at 30 and 90 minutes post-administration.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:46.079242+00:00"}
{"study_id": 47703, "supplement_id": 1287, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the safety and efficacy of N-acetyl-l-leucine (NALL) for treating Niemann-Pick disease type C, focusing on its potential to ameliorate lysosomal and metabolic dysfunction.", "results_summary": "Treatment with NALL for 12 weeks led to significantly better neurologic status compared to placebo, as measured by the SARA total score. Adverse events were similar between NALL and placebo, with no serious treatment-related events reported.", "population_specificity": "Patients aged 5 to 67 years with genetically confirmed Niemann-Pick disease type C.", "effective_dosage": "2 to 4 g per day for ages 4 to 12 (weight-based), 4 g per day for ages 13 and older, administered orally two to three times daily.", "study_duration": "12 weeks per treatment phase (crossover design).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:46.621627+00:00"}
{"study_id": 47704, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of leucine supplementation on body composition in male outpatients with gastrointestinal tract cancer undergoing chemotherapy.", "results_summary": "Leucine supplementation led to significant gains in body weight, BMI, fat-free mass (FFM), and appendicular skeletal muscle mass (ASMM) in the intervention group, though no significant intergroup differences were detected. The results were similar among cachectic patients, but the study noted uncertainty about whether the muscle mass increase was due to leucine or overall adequate calorie and macronutrient intake.", "population_specificity": "Older men diagnosed with gastrointestinal and appendix organ cancers undergoing chemotherapy.", "effective_dosage": "Not specified", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:47.281386+00:00"}
{"study_id": 47707, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to summarize the molecular mechanisms of E4BP4 in cancer cellular processes, its role in cancer immunotherapy, and its effects on antitumor drug resistance.", "results_summary": "The abstract highlights that E4BP4 dysregulation affects tumor development by modulating gene transcription, immune microenvironment, and multidrug resistance, suggesting potential therapeutic targeting.", "population_specificity": "Not specified (focus on tumor cells and immune microenvironment mechanisms).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:49.307600+00:00"}
{"study_id": 47706, "supplement_id": 1287, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether leucine-rich L- and D-phosphopeptides could self-assemble into nanofibers and induce targeted cell death in osteosarcoma cells without side effects or drug resistance.", "results_summary": "The peptides self-assembled in the nuclei of osteosarcoma cells, inducing cell death through multiple modalities and membrane disruption, with no side effects on other cells and no observed drug resistance after repeated treatment.", "population_specificity": "Osteosarcoma cells (in vitro study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:49.440614+00:00"}
{"study_id": 47708, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine if incorporating a glycine-leucine-glycine-lysine (GLGK)-linker would reduce kidney uptake of radiolabeled ADAPT6 compared to non-residualizing labeling strategies.", "results_summary": "The study found that the GLGK-linker did not significantly reduce renal retention of radiolabeled ADAPT6, while the [125I]I-HPEM labeling strategy showed significantly lower kidney uptake. The results suggest alternative molecular designs may be needed to reduce renal retention for different targeting agents.", "population_specificity": "NMRI mice", "effective_dosage": "Not specified", "study_duration": "4 hours post-injection", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:52.083979+00:00"}
{"study_id": 47709, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether leucine supplementation could attenuate doxorubicin-induced cardiac remodeling and oxidative stress in rats by analyzing catalase levels.", "results_summary": "Leucine supplementation reduced doxorubicin-induced cardiac remodeling and lowered catalase expression in the heart, suggesting a potential protective effect against oxidative stress. However, leucine did not prevent impaired body weight gain or alter raw heart weight.", "population_specificity": "Adult male Wistar rats", "effective_dosage": "5% Leucine-Enriched Diet", "study_duration": "28 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:52.929281+00:00"}
{"study_id": 47711, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the association between Leucine-rich alpha-2-glycoprotein (LRG) and endoscopic activity in ulcerative colitis (UC) patients, as well as its predictability for mucosal healing.", "results_summary": "LRG demonstrated high diagnostic accuracy for endoscopic activity (AUC 0.856) and was an independent predictor of endoscopic remission. Higher LRG levels correlated with more severe endoscopic activity and were useful for monitoring treatment efficacy.", "population_specificity": "214 patients with ulcerative colitis who underwent total colonoscopy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:53.821726+00:00"}
{"study_id": 47710, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to elucidate the structural mechanism of LRRK2 recruitment and activation by Rab29, providing insights into LRRK2 inhibitor design for Parkinson's disease treatment.", "results_summary": "The study revealed cryo-EM structures of Rab29-LRRK2 complexes in three oligomeric states, showing Rab29 induces a tetrameric assembly of LRRK2 with kinase-active and inactive protomers. The findings resemble the active-like state trapped by the inhibitor DNL201, offering structural insights for LRRK2 inhibitor development.", "population_specificity": "Not specified (structural study, not human trial)", "effective_dosage": "Not available", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:54.338972+00:00"}
{"study_id": 47712, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of 5 g leucine supplementation combined with resistance training on adipokine markers and body composition in untrained perimenopausal and postmenopausal women.", "results_summary": "Leucine supplementation led to higher leptin concentrations compared to placebo, while visfatin was higher in the placebo group. Both groups showed increases in visceral adipose tissue and fat-free mass, with significant decreases in adiponectin in both groups and MCP-1 only in the placebo group.", "population_specificity": "Untrained perimenopausal and postmenopausal women", "effective_dosage": "5 g per day", "study_duration": "10 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:54.541454+00:00"}
{"study_id": 47713, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the role of leucine-rich repeat containing 15 (LRRC15) in TGF-\u03b21-induced fibroblastic differentiation of human periodontal ligament cells (hPDLCs).", "results_summary": "The study found that LRRC15 was significantly upregulated during fibroblastic differentiation and played a critical role in activating the integrin-mediated cell adhesion signal pathway, which regulated differentiation, proliferation, and migration of PDL fibroblasts. Inhibition of LRRC15 disrupted these processes and altered cell morphology.", "population_specificity": "Human periodontal ligament cells (hPDLCs) cultured from periodontal ligament tissue.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:55.611501+00:00"}
{"study_id": 47714, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of PHLPP2 in diabetic retinopathy (DR) and assess whether reducing PHLPP2 levels could protect retinal structure and function in DR rat models.", "results_summary": "Reducing PHLPP2 levels improved visual function, reduced retinal damage, and decreased apoptosis, oxidative stress, and proinflammatory responses in DR rats. These effects were mediated through the AKT-GSK-3\u03b2-Nrf2 signaling pathway.", "population_specificity": "Streptozotocin-induced diabetic rat models.", "effective_dosage": "Not specified (intravitreal administration of adeno-associated viruses expressing shRNA targeting PHLPP2).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:57.795276+00:00"}
{"study_id": 47715, "supplement_id": 1287, "safety_score": "30", "efficacy_score": 20, "quality_score": 65, "study_goal": "The researchers aimed to determine the effects of leucine supplementation on skeletal muscle in male and female ApcMin/+ mice to assess its potential for mitigating cancer cachexia-induced muscle wasting.", "results_summary": "Leucine supplementation reduced survival rates, body mass, and muscle mass in male mice but had no effect in females. It lowered inflammatory gene expression in males but showed no impact on protein balance or myogenesis in either sex.", "population_specificity": "Male and female ApcMin/+ mice (a model for cancer cachexia) and their wild-type littermates.", "effective_dosage": "1.5% leucine-supplemented water.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:58.374656+00:00"}
{"study_id": 47716, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of glucocorticoid-induced leucine zipper (GILZ) expression changes in muscle strain during exercise, particularly in the context of statin therapy interactions.", "results_summary": "The study found a significant downregulation of GILZ mRNA after exercise training, with stronger effects observed after strength training compared to endurance exercise, suggesting muscle strain plays a key role.", "population_specificity": "32 healthy individuals", "effective_dosage": "Not available", "study_duration": "Single bout of standardized exercise", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:59.278917+00:00"}
{"study_id": 47718, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 30, "study_goal": "The researchers aimed to discuss the pathophysiology and clinical presentation of anti-LGI1 autoimmune limbic encephalitis (LE) in a patient with thymoma and additional autoantibodies.", "results_summary": "The study presented an unusual case of LGI1 autoimmune LE with anti-AChR and anti-striational antibodies in a thymoma patient, highlighting unique clinical manifestations but did not evaluate Leucine's effects.", "population_specificity": "A patient with thymoma and autoimmune LE associated with LGI1, anti-AChR, and anti-striational antibodies.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:01.725620+00:00"}
{"study_id": 47717, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate whether leucine supplementation improves myocardial function and key signaling pathways in a rat model of heart failure with preserved ejection fraction (HFpEF).", "results_summary": "Leucine supplementation improved diastolic function, hemodynamics, and reduced stiffness, fibrosis, and hypertrophy in HFpEF rats. It also enhanced mitochondrial respiratory function and suppressed HDAC4 expression, indicating potential therapeutic benefits for HFpEF.", "population_specificity": "Female ZSF1 rats (obese rats with established HFpEF).", "effective_dosage": "Standard chow enriched with 3% leucine.", "study_duration": "12 weeks (from 20 to 32 weeks of age).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:02.556188+00:00"}
{"study_id": 47719, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine whether leucine supplementation during energy restriction could reduce fat-free mass loss, enhance fat mass loss, and improve glucose tolerance in adults with metabolic syndrome components.", "results_summary": "Leucine supplementation preserved fat-free mass and lean tissue mass, particularly in men, but did not improve glucose metabolism or metabolic syndrome components. The effects were statistically significant but limited to body composition changes.", "population_specificity": "Adults aged 20-65 with increased waist circumference and at least one other metabolic syndrome component.", "effective_dosage": "3 g/day of leucine", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:02.661310+00:00"}
{"study_id": 47721, "supplement_id": 1287, "safety_score": "80", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether leucine supplementation could reduce frailty, as measured by a frailty index, in older nursing home residents.", "results_summary": "The study found no significant differences in frailty index levels between the leucine and placebo groups after 13 weeks, indicating leucine did not modify frailty in this population.", "population_specificity": "Older institutionalized males and females aged 65+ without dementia, living in nursing homes.", "effective_dosage": "6 g/day of leucine or placebo (lactose).", "study_duration": "13 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:03.616450+00:00"}
{"study_id": 47720, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if leucine could provide neuroprotection and reduce blood-brain barrier disruption during early cerebral ischemia-reperfusion, as well as its effects on S6 and Akt phosphorylation.", "results_summary": "Leucine reduced blood-brain barrier disruption (-34%) and cortical infarct size (-42%) but did not further affect the already elevated phosphorylation of S6 or Akt. The study suggests leucine may offer neuroprotection during early ischemia-reperfusion.", "population_specificity": "Rats subjected to middle cerebral artery occlusion (MCAO) and reperfusion.", "effective_dosage": "5 \u00b5L of 20 mM L-leucine injected into the left lateral ventricle.", "study_duration": "Single administration during early ischemia-reperfusion (within 2 hours of reperfusion).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:05.090407+00:00"}
{"study_id": 192826, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether dileucine (DILEU) supplementation enhances resistance training adaptations compared to leucine (LEU) or placebo (PLA).", "results_summary": "DILEU supplementation at 2 grams daily significantly improved lower body strength (leg press 1RM) and muscular endurance (leg press RTF) compared to PLA and LEU, respectively, but showed no significant differences in other measures.", "population_specificity": "34 resistance-trained males (age: 28.3 \u00b1 5.9 years).", "effective_dosage": "2 grams daily of DILEU monohydrate, LEU, or PLA.", "study_duration": "10 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:05.834163+00:00"}
{"study_id": 192827, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the potential of leucine supplementation as part of nutritional strategies for managing sarcopenia in older adults.", "results_summary": "Leucine supplementation was discussed as a promising nutritional strategy for addressing sarcopenia, alongside other interventions like resistance training and anti-inflammatory nutrients, though specific efficacy data were not detailed in the abstract.", "population_specificity": "Older adults with or at risk of sarcopenia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:05.836188+00:00"}
{"study_id": 192831, "supplement_id": 1287, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and safety of leucine-enriched essential amino acid (LEAA) supplementation in improving muscle density and quality of life in patients with knee osteoarthritis.", "results_summary": "The study found that LEAA supplementation significantly improved muscle density (measured via DEXA scan) and quality of life (SF-36 scores) compared to the control group, with no significant adverse effects or safety concerns reported.", "population_specificity": "Patients with symptomatic knee osteoarthritis (n=65, experimental group=32, control group=33).", "effective_dosage": "12 g of LEAAs daily.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:11.423539+00:00"}
{"study_id": 192830, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to assess the feasibility, acceptability, and appetite response of a leucine-enriched glycomacropeptide (GMP) drink compared to whey protein isolate (WHEY) in older adults.", "results_summary": "The study found that leucine-enriched GMP was not less satiating than WHEY, but it had lower palatability and acceptability. Gut hormone responses and subjective appetite did not differ between GMP and WHEY, and there was no difference in ad libitum meal intake.", "population_specificity": "Older adults (mean age ~70 years, predominantly female).", "effective_dosage": "27g GMP + 3g leucine in 350 mL water.", "study_duration": "Single administration with 240-minute follow-up.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:11.449721+00:00"}
{"study_id": 192835, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review existing literature on whey protein's mouthdrying effects and propose novel mitigation strategies to improve consumer acceptance, particularly in older adults.", "results_summary": "The review found that whey protein's mouthdrying is linked to electrostatic interactions, mucoadhesion, and acidity, but no existing studies proposed ingredient modifications to address this. It recommends increasing lubrication as a potential solution.", "population_specificity": "Older adults, active adults, and the general population.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:11.492478+00:00"}
{"study_id": 192836, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare the clinical effects of standard whey protein-based oral supplements versus leucine-enriched oral supplements in cancer patients undergoing systemic treatment.", "results_summary": "Nutritional parameters remained stable in both groups, with extracellular mass tending to increase in the leucine-enriched group. Functionality improved in both groups, but no significant differences were highlighted between the two supplement types.", "population_specificity": "Patients with cancer undergoing systemic treatment.", "effective_dosage": "Not specified", "study_duration": "Twelve weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:12.171302+00:00"}
{"study_id": 192838, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of leucine, in combination with whey protein and vitamin D, on muscle mass, strength, and function in patients with sarcopenia.", "results_summary": "Leucine supplementation, combined with whey protein and vitamin D, significantly improved appendicular muscle mass in sarcopenia patients. When paired with physical exercise, it also enhanced handgrip strength and physical performance scores, but no significant improvements were observed without exercise.", "population_specificity": "Patients with sarcopenia", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:13.705733+00:00"}
{"study_id": 192837, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to assess whether a food supplement containing leucine, combined with pelvic floor muscle training (PFMT), improved urinary symptoms in women with stress-predominant urinary incontinence.", "results_summary": "The study found that the treatment group (supplement + PFMT) showed significant improvements in urinary symptoms (UDI-6 and IIQ-7 scores) and biomechanical integrity compared to baseline, though between-group differences were limited to vaginal squeeze pressure and PGI-S scores. The control group (placebo + PFMT) did not show significant improvements in these outcomes.", "population_specificity": "Women with stress-predominant urinary incontinence.", "effective_dosage": "Not specified.", "study_duration": "Six weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:15.027896+00:00"}
{"study_id": 192839, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effectiveness of leucine-enriched whey protein supplementation combined with resistance training on maintaining skeletal muscle mass and strength in older adults with sarcopenia after a de-training period.", "results_summary": "The study found that combined resistance training and leucine-enriched whey protein supplementation significantly increased muscle mass and strength post-intervention, with sustained benefits even after 24 weeks of de-training compared to resistance training alone.", "population_specificity": "Older adults aged \u2265 65 years with sarcopenia in Hyogo, Japan.", "effective_dosage": "2,300 mg of leucine (as part of 11.0 g whey protein) twice weekly.", "study_duration": "24 weeks of intervention followed by 24 weeks of de-training.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:20.098484+00:00"}
{"study_id": 192828, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers sought to measure vitamin B12 and homocysteine levels in contemporary trial participants with early Parkinson's disease and determine their association with clinical progression.", "results_summary": "The study found higher baseline B12 levels in contemporary trials compared to the older DATATOP study, largely due to increased B12 supplement intake, while homocysteine levels remained similar. Initiation of levodopa was associated with increased homocysteine in those not taking B12 supplements, but no associations were found between baseline B12 or homocysteine levels and clinical progression.", "population_specificity": "Participants with early Parkinson's disease who had not started dopaminergic treatment.", "effective_dosage": "Not mentioned", "study_duration": "Not specified", "interactions": "Levodopa was associated with increased homocysteine in those not taking B12 supplements.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:20.619899+00:00"}
{"study_id": 192829, "supplement_id": 1287, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to understand the mechanisms by which leucine governs skeletal muscle protein metabolism in healthy adults and its potential therapeutic applications.", "results_summary": "PBPK-PD models revealed leucine's role in skeletal muscle protein metabolism and identified optimal dosing regimens for treating conditions like sickle-cell disease and recurrent hypoglycemia. The models also explored leucine's potential in minimizing drug side effects in seizure disorders and its role in anticancer strategies targeting amino acid deprivation.", "population_specificity": "Healthy adults and specific patient populations (e.g., sickle-cell disease, recurrent hypoglycemia, seizure disorders).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:22.252592+00:00"}
{"study_id": 74468, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to investigate the role of lutein in lowering systemic factor D levels in early AMD cases and its potential implications for AMD intervention.", "results_summary": "Preliminary findings suggest lutein supplementation in early AMD cases reduced systemic factor D levels, supporting anti-factor D intervention as a potential approach to control AMD development.", "population_specificity": "Elderly populations in Western, industrialized countries with early age-related macular degeneration (AMD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:29.513238+00:00"}
{"study_id": 74469, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the role of supplements, including Lutein, in the treatment and prevention of age-related macular degeneration (AMD).", "results_summary": "The abstract indicates that oral intake of supplements, including Lutein, may be beneficial in preventing the progression of AMD, though specific results for Lutein are not detailed. The review summarizes current knowledge about micronutrients used in AMD management.", "population_specificity": "Individuals with or at risk of age-related macular degeneration (AMD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:29.859363+00:00"}
{"study_id": 74463, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effectiveness of lutein, in combination with other supplements, in reducing the progression of age-related macular degeneration (AMD).", "results_summary": "The study found that lutein, along with zinc, vitamin C, vitamin E, and zeaxanthin, reduced the risk of developing neovascular complications of AMD, though it did not significantly impact atrophic complications.", "population_specificity": "Individuals with age-related macular degeneration (AMD).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:29.870217+00:00"}
{"study_id": 74464, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of FSH stimulation on hormone production and gene expression in granulosa cells from natural vs. stimulated IVF cycles.", "results_summary": "The study found higher AMH mRNA expression and AMH protein levels in granulosa cells from natural IVF cycles after FSH stimulation, with a positive correlation between AMH and progesterone levels.", "population_specificity": "Women undergoing natural or conventional gonadotropin-stimulated IVF.", "effective_dosage": "1 IU/mL FSH", "study_duration": "48 hours and 6 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:29.931056+00:00"}
{"study_id": 74474, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the efficacy of lutein supplementation in improving macular pigment optical density (MPOD) and visual acuity (VA) in individuals with or at risk of age-related macular degeneration (AMD).", "results_summary": "Lutein supplementation significantly improved MPOD with a mean difference of 0.09 (p < 0.00001) and showed a milder improvement in VA (mean difference -0.04, p = 0.05). A daily dose of 10 mg was as effective as higher doses.", "population_specificity": "AMD patients or individuals at risk of AMD", "effective_dosage": "10 mg daily (effective dose)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:30.514464+00:00"}
{"study_id": 74467, "supplement_id": 1305, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the role of lutein and zeaxanthin in modulating oxidative stress and inflammation related to retinopathy of prematurity (ROP) and diabetic retinopathy (DR), and their potential in preventing or reducing disease progression.", "results_summary": "The study found that lutein supplementation showed anti-inflammatory effects in preterm infants and a trend of decreased ROP severity. Lower serum levels of lutein and zeaxanthin were observed in patients with non-proliferative DR compared to normal subjects.", "population_specificity": "Preterm infants (for ROP) and working-age adults (for DR).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:30.592046+00:00"}
{"study_id": 74466, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the relationship between retinal and brain lutein and zeaxanthin concentrations in humans, particularly in the context of cognitive function.", "results_summary": "Retinal macular pigment carotenoids (lutein, meso-zeaxanthin, and zeaxanthin combined) were significantly related to lutein and zeaxanthin concentrations in the occipital cortex, but not the hippocampus. Retinal lutein (plus meso-zeaxanthin) specifically correlated with occipital cortex lutein.", "population_specificity": "Men and women aged >50 years with either normal cognitive function or Alzheimer's disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:30.594838+00:00"}
{"study_id": 74473, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether supplementation with lutein (alongside other macular carotenoids) improves macular pigment levels, vision, and cognitive function in Alzheimer's disease patients compared to controls.", "results_summary": "The study found that lutein supplementation significantly increased serum lutein levels and macular pigment, and improved contrast sensitivity in both AD patients and controls, but did not significantly affect cognitive function.", "population_specificity": "31 Alzheimer's disease patients and 31 age-matched control subjects.", "effective_dosage": "10 mg lutein (as part of Macushield, which also contained 10 mg meso-zeaxanthin and 2 mg zeaxanthin), administered daily.", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:31.077332+00:00"}
{"study_id": 74478, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether daily Chlorella intake, which increases serum carotenoids like lutein, improves serum lipid profiles in mildly hypercholesterolemic subjects.", "results_summary": "The Chlorella group showed a significant 89.6% increase in lutein/zeaxanthin levels compared to placebo, alongside improvements in triglycerides, total cholesterol, and other lipid markers, suggesting carotenoid-related benefits.", "population_specificity": "Mildly hypercholesterolemic subjects (n=63).", "effective_dosage": "5 g/day of Chlorella.", "study_duration": "4-week intervention.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:37.960705+00:00"}
{"study_id": 74476, "supplement_id": 1305, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether daily consumption of lutein-enriched egg yolks could increase plasma lutein concentrations and influence serum lipid profiles, particularly in individuals with early signs of AMD.", "results_summary": "The study found that lutein-enriched egg yolks significantly increased plasma lutein concentrations (83% higher than control) without altering serum lipid profiles. Cholesterol absorbers showed higher HDL cholesterol and greater lutein absorption compared to other groups.", "population_specificity": "Men and women with early signs of AMD in at least one eye, otherwise healthy.", "effective_dosage": "1.5 lutein-rich egg yolks daily in a buttermilk drink.", "study_duration": "1 year", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:38.386844+00:00"}
{"study_id": 74477, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the bioavailability of lutein from human milk versus lutein-fortified infant formula and identify factors affecting carotenoid delivery.", "results_summary": "The study found no significant difference in lutein bioaccessibility between human milk and infant formula, but lutein delivery was 4.5 times greater from human milk due to more efficient intestinal absorption. Absorption efficiency increased with lower lutein concentrations in milk, and no effects were observed from lactation stage, lipid content, lutein source, or formula form.", "population_specificity": "Human milk samples from mothers 1-6 months postpartum and lutein-fortified infant formula samples.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:38.814881+00:00"}
{"study_id": 74482, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate the impact of lutein supplementation, combined with other macular carotenoids, on visual function in normal subjects and those with early age-related macular degeneration (AMD).", "results_summary": "The abstract does not report specific results regarding lutein's effects, as it describes the study design and outcomes to be measured rather than findings.", "population_specificity": "Normal subjects (Trial 1) and subjects with early AMD (Trial 2).", "effective_dosage": "10 mg lutein (daily, inferred).", "study_duration": "12 months (Trial 1) and 24 months (Trial 2).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:38.858318+00:00"}
{"study_id": 74480, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "To determine if neonatal lutein supplementation in the first hours of life reduces oxidative stress in newborns during the immediate postpartum period.", "results_summary": "Lutein supplementation significantly increased biological antioxidant potential (BAP) and reduced total hydroperoxide (TH) levels in newborns compared to untreated controls, indicating reduced oxidative stress.", "population_specificity": "150 newborns (47 controls, 103 supplemented).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Single dose administered on the first day postpartum, with measurements taken at birth and 48 hours later.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:39.123563+00:00"}
{"study_id": 74483, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to determine if increased fruit and vegetable (F&V) intake, which includes lutein, influenced the carotenoid content and antioxidant-related enzymes in HDL in subjects with type 2 diabetes (T2D).", "results_summary": "The study found that increased F&V intake significantly elevated lutein levels in serum, HDL2, and HDL3 (p = 0.012), alongside enhanced activity of antioxidant enzymes like PON-1 and LCAT in HDL3. These changes suggest improved cardioprotective properties of HDL.", "population_specificity": "Eighty obese subjects with type 2 diabetes.", "effective_dosage": "\u22656 portions/day of fruits and vegetables (specific lutein dosage not isolated).", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:39.415143+00:00"}
{"study_id": 74479, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "To investigate the impact of different macular carotenoid formulations, including lutein, on macular pigment optical density and visual performance in early age-related macular degeneration.", "results_summary": "Group 2 (10 mg/day meso-zeaxanthin, 10 mg/day lutein, and 2 mg/day zeaxanthin) and Group 3 (17 mg/day meso-zeaxanthin, 3 mg/day lutein, and 2 mg/day zeaxanthin) showed statistically significant increases in macular pigment optical density and improvements in contrast sensitivity, while Group 1 (20 mg/day lutein and 2 mg/day zeaxanthin) showed limited effects.", "population_specificity": "Subjects with early age-related macular degeneration (n=52).", "effective_dosage": "Group 1: 20 mg/day lutein; Group 2: 10 mg/day lutein; Group 3: 3 mg/day lutein.", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:39.940609+00:00"}
{"study_id": 74486, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to assess the effects of dietary advice on cardiovascular risk factors, including small increases in plasma antioxidants like lutein.", "results_summary": "The study found small increases in lutein levels with dietary advice, though there was heterogeneity in trial effects. No significant adverse effects or detailed efficacy data specific to lutein were reported.", "population_specificity": "Healthy adults", "effective_dosage": "Not specified", "study_duration": "3 to 36 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:45.307253+00:00"}
{"study_id": 74491, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The abstract does not mention Lutein or any research goals related to it.", "results_summary": "The abstract does not discuss Lutein or its effects.", "population_specificity": "Patients with macular telangiectasia type 2 (Mac Tel 2).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:45.603488+00:00"}
{"study_id": 74488, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of lutein, among other nutrients, in reducing the risk of cataracts based on epidemiologic and limited intervention trial data.", "results_summary": "The study suggests that diets optimized for lutein/zeaxanthin may reduce the risk of nuclear cataracts, though evidence for other cataract types is limited. Observational studies support salutary effects, but intervention trial data are sparse.", "population_specificity": "Elderly individuals and those with carbohydrate metabolism-related problems.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:46.286010+00:00"}
{"study_id": 74485, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate whether lutein/zeaxanthin could replace beta-carotene in the AREDS formulation to enhance benefits for AMD while avoiding increased lung cancer risk in former smokers.", "results_summary": "The study suggested that lutein/zeaxanthin could replace beta-carotene in the AREDS formulation, potentially providing incremental benefits for AMD beyond the original formulation. No adverse effects of lutein were mentioned, but its specific efficacy was implied rather than directly tested in this review.", "population_specificity": "Individuals at risk for or with age-related macular degeneration (AMD) and cataracts, particularly former smokers.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:46.362670+00:00"}
{"study_id": 74489, "supplement_id": 1305, "safety_score": "85", "efficacy_score": 70, "quality_score": 90, "study_goal": "The researchers aimed to evaluate whether adding lutein + zeaxanthin to the AREDS formulation reduces the risk of progression to advanced AMD.", "results_summary": "The addition of lutein + zeaxanthin to the AREDS formulation did not significantly reduce the risk of progression to advanced AMD overall, but subgroup analyses suggested benefits in participants with low dietary intake of lutein + zeaxanthin. A formulation without beta-carotene may be preferable, especially for smokers or former smokers.", "population_specificity": "Older adults with intermediate AMD.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:46.709196+00:00"}
{"study_id": 74490, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Chlorella supplementation (providing lutein) could reduce erythrocyte phospholipid hydroperoxide (PLOOH) concentrations and improve antioxidant status in senior subjects.", "results_summary": "After 2 months of Chlorella supplementation (22.9 mg lutein/day), erythrocyte and plasma lutein concentrations increased, and PLOOH levels decreased, suggesting improved antioxidant status and potential benefits for erythrocyte function and dementia prevention.", "population_specificity": "12 normal senior subjects", "effective_dosage": "22.9 mg lutein/day (via 8 g Chlorella/day)", "study_duration": "2 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:46.965853+00:00"}
{"study_id": 74492, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to investigate the dose-response effect of fruit and vegetable intake, including lutein, on insulin resistance in overweight individuals at high risk of cardiovascular disease.", "results_summary": "The study found a significant linear increase in serum lutein status across groups, indicating good compliance, but no significant effect on insulin resistance measures. Increased F&V consumption did not impact insulin resistance when body weight was maintained.", "population_specificity": "Overweight individuals at high risk of cardiovascular disease (mean age 56 years).", "effective_dosage": "Not specified (lutein levels increased with higher F&V intake: 1.8, 3.8, and 7.0 portions per day).", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:48.692610+00:00"}
{"study_id": 74484, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the role of lutein, as part of the AREDS2 formulation, in reducing the risk of progression to advanced age-related macular degeneration (AMD).", "results_summary": "The study found that oral supplementation with lutein (as part of the AREDS2 formulation) reduced the risk of progression to advanced AMD, though the impact was more pronounced in neovascular AMD rather than atrophic AMD.", "population_specificity": "Individuals at risk for or with early-stage age-related macular degeneration (AMD).", "effective_dosage": "Not specified in the abstract (part of AREDS2 formulation).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:48.730277+00:00"}
{"study_id": 74496, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to evaluate the effects of lutein supplementation, alone and in combination with lycopene, on carotid artery intima-media thickness (CAIMT) in subjects with subclinical atherosclerosis.", "results_summary": "Lutein supplementation significantly increased serum lutein concentrations and reduced CAIMT, with greater effects observed when combined with lycopene. The change in CAIMT was inversely associated with increases in serum lutein and lycopene concentrations.", "population_specificity": "Chinese subjects aged 45-68 years with subclinical atherosclerosis.", "effective_dosage": "20 mg lutein/day (alone or with 20 mg lycopene/day).", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:54.763667+00:00"}
{"study_id": 74494, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of fenofibrate and ER-niacin on plasma xanthophylls (lutein and zeaxanthin) and their relationship with lipoprotein levels in dyslipidemic patients.", "results_summary": "Lutein levels were unaffected by fenofibrate but inversely correlated with apoB and LDL-C changes, while ER-niacin increased xanthophyll levels (~30%) without lipoprotein correlations. ApoA-II in HDL bound more lutein than apoA-I in vitro.", "population_specificity": "66 dyslipidemic patients", "effective_dosage": "Not specified for lutein (study focused on fenofibrate 160 mg/day and ER-niacin 0.5 g/day for 3 weeks, then 1 g/day)", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:54.879903+00:00"}
{"study_id": 74495, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to examine the expression, localization, and function of TIMP3 during ovulation in women, including its impact on granulosa-lutein cell viability.", "results_summary": "TIMP3 mRNA expression increased in granulosa cells during ovulation, and TIMP3 protein was localized in granulosa and theca cell layers. Exogenous TIMP3 reduced granulosa-lutein cell viability by 60%.", "population_specificity": "Women undergoing ovulation, including those in the periovulatory period and in vitro fertilization.", "effective_dosage": "Increasing concentrations of recombinant TIMP3 (specific amounts not stated).", "study_duration": "24-hour treatment for viability assessment.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:55.015297+00:00"}
{"study_id": 74493, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether a short-term intervention with a kale-derived oleaginous extract (containing lutein and zeaxanthin) could increase plasma xanthophyll concentrations and macular pigment optical density (MPOD) in patients with non-exudative AMD.", "results_summary": "The kale group showed significant increases in plasma xanthophyll concentrations and MPOD after 4 weeks of intervention, but these improvements declined during the 4-week washout period, though remaining higher than baseline. The findings suggest that macular xanthophyll distribution is more dynamic than previously assumed.", "population_specificity": "20 patients with non-exudative age-related macular degeneration (AMD).", "effective_dosage": "10 mg lutein and 3 mg zeaxanthin per day (delivered in 50 mL of a beverage).", "study_duration": "4-week intervention (total study duration: 10 weeks, including run-in and washout).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:55.179856+00:00"}
{"study_id": 74497, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of broccoli intake, particularly its impact on plasma lutein levels and markers of inflammation in young male smokers.", "results_summary": "Broccoli intake significantly increased plasma lutein levels by 39%, but no significant effect was observed on inflammatory markers like TNF-\u03b1, IL-6, or IL-6sR. The reduction in CRP was independent of lutein and folate variations.", "population_specificity": "Young male smokers", "effective_dosage": "250 g/day of broccoli", "study_duration": "10 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:55.189281+00:00"}
{"study_id": 74498, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to determine the therapeutic role of carotenoids, including lutein, in atherosclerotic disease, specifically whether their anti-atherosclerotic effects are limited to primary prevention or can improve outcomes in existing cardiovascular and cerebrovascular diseases.", "results_summary": "The study found that lutein and other carotenoids exhibit anti-oxidant activity that attenuates atherosclerotic inflammation, improves endothelial function, and enhances metabolic profiles (e.g., lowering LDL and improving blood pressure). However, randomized controlled trials did not show a reduction in major cardiovascular or cerebrovascular events.", "population_specificity": "General population with a focus on atherosclerotic disease risk or progression.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:55.430533+00:00"}
{"study_id": 74499, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to examine the role of lutein and zeaxanthin in protecting the eye from light and oxidative damage, and their potential to prevent age-related degenerative diseases like macular degeneration and cataracts.", "results_summary": "The study found that lutein and zeaxanthin are highly concentrated in the eye and may help mitigate light and oxygen-induced damage, with epidemiologic evidence suggesting an inverse association between their levels and age-related ocular diseases. The carotenoids act as blockers of blue-light damage and quenchers of oxygen free radicals.", "population_specificity": "Human eye tissues and general population (epidemiologic research).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:59.033967+00:00"}
{"study_id": 74500, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to determine the long-term effect of lutein supplementation, combined with zeaxanthin, omega-3 fatty acids, and antioxidants, on macular pigment optical density (MPOD) in patients with non-exudative age-related macular degeneration (AMD).", "results_summary": "The study found that supplementation significantly increased MPOD parameters and improved best-corrected visual acuity (BCVA) in AMD patients, with no difference in efficacy between once-daily and twice-daily dosages. The placebo group showed a significant decrease in MPOD, highlighting the protective effect of supplementation.", "population_specificity": "Patients with non-exudative AMD (n=172, with 145 completing the study).", "effective_dosage": "10 mg lutein / 1 mg zeaxanthin / omega-3-LCPUFAs (100 mg DHA, 30 mg EPA) / antioxidants, administered once or twice daily.", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:59.698992+00:00"}
{"study_id": 74506, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to assess the effects of dietary advice on cardiovascular risk factors, including small increases in plasma antioxidants like lutein.", "results_summary": "The study found small increases in lutein levels with dietary advice, but there was heterogeneity in trial effects. No significant adverse effects or detailed efficacy data specific to lutein were reported.", "population_specificity": "Healthy adults", "effective_dosage": "Not specified", "study_duration": "3 to 36 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:02.431987+00:00"}
{"study_id": 74501, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the sensitivity of HPLC-PDA and HPLC/MS/MS methods for quantifying lutein and other carotenoids in human plasma samples.", "results_summary": "The study found that HPLC-PDA was up to 8 times more sensitive for lutein than HPLC/MS/MS, and MS/MS signals for lutein were enhanced by matrix components. Both detectors showed similar suitability for other analytes, but MS/MS allowed quantitation of minor compounds.", "population_specificity": "Human subjects from two clinical trials (specific details not provided in the abstract).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:03.145453+00:00"}
{"study_id": 74504, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of dietary interventions (Mediterranean vs. Healthy Eating) on serum and colonic concentrations of lutein and other carotenoids in individuals at increased risk of colon cancer.", "results_summary": "The study found that both dietary interventions significantly increased serum lutein levels, with the Healthy Eating diet also increasing colonic carotenoid concentrations. Changes in serum and colon concentrations were strongly associated for some carotenoids, suggesting serum levels could serve as a proxy for colonic concentrations.", "population_specificity": "120 persons at increased risk of colon cancer", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:03.424217+00:00"}
{"study_id": 74505, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review recent scientific evidence on the benefits of lutein and zeaxanthin in preventing age-related eye diseases like AMD and cataracts.", "results_summary": "Lutein and zeaxanthin were found to protect the macula from blue light damage, improve visual acuity, and reduce oxidative stress, with links to lower risks of AMD and cataracts. The study also highlights dietary sources and newly developed high-lutein functional foods.", "population_specificity": "Elderly population (focus on age-related eye diseases).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:03.457118+00:00"}
{"study_id": 74502, "supplement_id": 1305, "safety_score": "85", "efficacy_score": 30, "quality_score": 90, "study_goal": "The researchers aimed to determine whether daily oral supplementation with lutein/zeaxanthin affects the risk for cataract surgery.", "results_summary": "Daily lutein/zeaxanthin supplementation showed no statistically significant overall effect on rates of cataract surgery or vision loss, though a subgroup with low dietary intake showed a reduced risk. The hazard ratio for progression to cataract surgery was 0.96 (not significant) overall but 0.68 (significant) for those with the lowest dietary intake.", "population_specificity": "4,203 participants aged 50-85 years at risk for progression to advanced age-related macular degeneration.", "effective_dosage": "10 mg lutein and 2 mg zeaxanthin daily.", "study_duration": "Median follow-up of 4.7 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:04.005966+00:00"}
{"study_id": 74503, "supplement_id": 1305, "safety_score": "85", "efficacy_score": 60, "quality_score": 90, "study_goal": "The researchers aimed to determine whether adding lutein + zeaxanthin to the AREDS formulation reduces the risk of progression to advanced AMD and to evaluate the safety of substituting beta carotene with lutein + zeaxanthin.", "results_summary": "The study found no statistically significant reduction in progression to advanced AMD with lutein + zeaxanthin supplementation. However, lutein + zeaxanthin was suggested as a safer carotenoid substitute due to potential increased lung cancer risk with beta carotene in former smokers.", "population_specificity": "4203 participants aged 50 to 85 years at risk for progression to advanced AMD with bilateral large drusen or large drusen in one eye and advanced AMD in the fellow eye.", "effective_dosage": "10 mg lutein + 2 mg zeaxanthin daily.", "study_duration": "Median follow-up of 5 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:05.225780+00:00"}
{"study_id": 74508, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether lutein supplementation could enhance total antioxidant status (TAS) in preterm infants compared to a placebo.", "results_summary": "The study found no statistically significant difference in TAS between the lutein and placebo groups, but identified a weak but significant linear correlation between plasma lutein/zeaxanthin concentrations and TAS.", "population_specificity": "Preterm infants with gestational age \u226434 weeks.", "effective_dosage": "0.5 mg lutein + 0.02 mg zeaxanthin per kg per day.", "study_duration": "From the 7th day of life until the 40th week of postmenstrual age or discharge.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:08.153089+00:00"}
{"study_id": 74507, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the effects of a 12-month intervention with lutein, zeaxanthin, and \u03c9-3 LC-PUFAs on plasma xanthophyll levels, macular pigment optical density, and antioxidant capacity in patients with nonexudative AMD.", "results_summary": "The study found that supplementation significantly increased plasma carotenoid concentrations and macular pigment optical density, with higher doses improving fatty acid profiles and elevating antioxidant capacity. These effects were sustained throughout the 12-month intervention.", "population_specificity": "172 individuals with nonexudative AMD (145 completed the study).", "effective_dosage": "Group 1: 10 mg lutein, 1 mg zeaxanthin, 100 mg DHA, and 30 mg EPA daily; Group 2: double the dose of Group 1.", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:08.759250+00:00"}
{"study_id": 74509, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether lutein supplementation affects biomarkers related to cardiovascular disease (CVD) in healthy nonsmokers.", "results_summary": "Lutein supplementation significantly increased plasma lutein and total antioxidant capacity (TAOC), reduced malondialdehyde (a marker of lipid peroxidation) in the 20 mg group, and decreased C-reactive protein (CRP) in a dose-dependent manner, suggesting reduced inflammation and oxidative stress.", "population_specificity": "Healthy nonsmokers", "effective_dosage": "10 mg/day or 20 mg/day", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:10.379715+00:00"}
{"study_id": 74510, "supplement_id": 1305, "safety_score": "85", "efficacy_score": 75, "quality_score": 90, "study_goal": "The researchers aimed to examine the effect of lutein supplementation on visual function in healthy drivers with long-term light exposure.", "results_summary": "Lutein supplementation significantly increased serum lutein and macular pigment optical density (MPOD), improved contrast and glare sensitivity (especially in low light), and enhanced driving-related visual function scores, though visual acuity improvements were not statistically significant.", "population_specificity": "Healthy drivers with long-term light exposure (n=120).", "effective_dosage": "20 mg daily.", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:10.686692+00:00"}
{"study_id": 74512, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether oral supplementation of lutein and zeaxanthin could re-accumulate in the macula of patients with macular telangiectasia type 2.", "results_summary": "The study found that areas depleted of macular pigment in macular telangiectasia type 2 could not re-accumulate lutein and zeaxanthin after oral supplementation, indicating limited efficacy. Therapeutic trials with lutein showed no significant benefit for the disease.", "population_specificity": "Patients with macular telangiectasia type 2.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:11.789428+00:00"}
{"study_id": 74514, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential benefits of lutein in treating or preventing age-related macular degeneration (AMD).", "results_summary": "The study suggests that lutein, along with other micronutrients, may have beneficial effects in AMD by filtering short wavelength light and reducing oxidative and inflammatory damage. However, further prospective studies are needed to confirm these effects.", "population_specificity": "Individuals with or at risk of age-related macular degeneration (AMD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:12.316102+00:00"}
{"study_id": 74513, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether supplementation with lutein, zeaxanthin, and coantioxidants could improve functional and morphologic outcomes in individuals with early age-related macular degeneration (AMD).", "results_summary": "The study found that supplementation led to statistically significant improvements in best-corrected visual acuity (4.8 letters better at 36 months) and slower progression along the AMD severity scale. Higher serum lutein levels were associated with better visual acuity (1.4 letters per log-unit increase).", "population_specificity": "Adults aged 55+ with early AMD in one or both eyes.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Minimum 12 months, with follow-up up to 36 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:12.959308+00:00"}
{"study_id": 74511, "supplement_id": 1305, "safety_score": "90", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to determine the effects of supplemental lutein and zeaxanthin on serum levels and macular pigment optical density (MPOD) in Chinese patients with early age-related macular degeneration.", "results_summary": "The study found that lutein supplementation significantly increased serum lutein levels and MPOD, with the highest dose (20 mg/d) showing the greatest effect. Serum zeaxanthin levels also increased in the lutein plus zeaxanthin group, and no notable changes were observed in the placebo group.", "population_specificity": "Chinese patients older than 50 years with early age-related macular degeneration.", "effective_dosage": "10 mg/d (low lutein), 20 mg/d (high lutein), and 10 mg/d lutein plus 10 mg/d zeaxanthin.", "study_duration": "48 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:13.348466+00:00"}
{"study_id": 74516, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of whole egg consumption on plasma and lipoprotein carotenoids, particularly lutein and zeaxanthin, in individuals with metabolic syndrome (MetS).", "results_summary": "The study found that consuming 3 whole eggs daily significantly increased plasma lutein (+21%) and zeaxanthin (+48%), as well as their enrichment in HDL and LDL fractions. The yolk-free egg substitute group only showed increases in \u03b2-carotene, not lutein or zeaxanthin.", "population_specificity": "Participants with metabolic syndrome (MetS)", "effective_dosage": "3 whole eggs per day", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:17.367086+00:00"}
{"study_id": 74517, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore the potential of lutein as an antioxidant to protect retinal cells from oxidative stress-induced damage in conditions like diabetic retinopathy and retinopathy of prematurity.", "results_summary": "The study suggests that lutein, along with other antioxidants, may help mitigate oxidative damage in retinal ischemia/hypoxia, potentially offering therapeutic benefits for retinal diseases. However, specific efficacy data for lutein alone are not detailed.", "population_specificity": "Patients with retinal ischemic diseases such as diabetic retinopathy and retinopathy of prematurity.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:18.178871+00:00"}
{"study_id": 74515, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of different macular carotenoid formulations, including lutein, on macular pigment optical density (MPOD) and visual performance.", "results_summary": "Group 2 (10 mg lutein, 2 mg zeaxanthin, and 10 mg meso-zeaxanthin) showed statistically significant increases in MPOD and improvements in visual performance, while Group 1 (20 mg lutein and 2 mg zeaxanthin) showed only modest improvements in mesopic contrast sensitivity. Placebo showed no significant effects.", "population_specificity": "36 subjects (19 male, 17 female; mean age 51 \u00b1 13 years)", "effective_dosage": "Group 1: 20 mg lutein and 2 mg zeaxanthin; Group 2: 10 mg lutein, 2 mg zeaxanthin, and 10 mg meso-zeaxanthin", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:18.892611+00:00"}
{"study_id": 74518, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the biological properties and clinical value of lutein, particularly its antioxidant and photoprotective effects, and its potential role in reducing chronic disease risk.", "results_summary": "The abstract notes that lutein has important biological properties, including antioxidant and photoprotective activity, but no clinical trials have proven its clinical value. Observational studies suggest a link between high intake and reduced chronic disease risk, but evidence remains insufficient.", "population_specificity": "General population, with implied relevance to high-risk groups (e.g., smokers, asbestos workers) based on broader carotenoid discussion.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:19.553190+00:00"}
{"study_id": 74519, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether lutein and zeaxanthin influence cognitive function in older adults, using macular pigment density as a biomarker and examining their effects on various cognitive measures.", "results_summary": "The study found that lutein and zeaxanthin concentrations in brain tissue were associated with improved cognitive function, memory, and verbal fluency, particularly in older adults. A 4-month supplementation trial showed significant improvements in verbal fluency and memory, especially when lutein was combined with DHA.", "population_specificity": "Older adults, including centenarians and older women.", "effective_dosage": "12 mg/d lutein, alone or with 800 mg/d DHA.", "study_duration": "4 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:20.484349+00:00"}
{"study_id": 74521, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to analyze the carotenoid (including lutein) and nutrient content of commercial pumpkin seed oil and assess how roasting conditions affect its aromatic and nutraceutical properties.", "results_summary": "The study found that pumpkin seed oil contains lutein and other carotenoids, contributing to its nutraceutical properties. High-temperature roasting enhanced aromatic characteristics but mild roasting preserved therapeutic qualities.", "population_specificity": "Commercial pumpkin seed oil samples (12 samples analyzed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:20.705414+00:00"}
{"study_id": 74520, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the age dependence of macular pigment optical density (MPOD) and compare MPOD levels between healthy controls and patients with age-related macular degeneration (AMD).", "results_summary": "The study found that MPOD was reduced in AMD patients compared to healthy controls. Additionally, MPOD declined with age in AMD patients but not in healthy controls, suggesting a rationale for lutein supplementation in AMD patients.", "population_specificity": "85 healthy subjects (ages 21-79) and 96 AMD patients (ages 50-89).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:22.077315+00:00"}
{"study_id": 74522, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether daily supplementation with 10 mg of lutein and 2 mg of zeaxanthin could slow the progression of age-related macular degeneration (AMD).", "results_summary": "Baseline macular pigment optical density (MPOD) was unusually high in enrolled subjects, consistent with their habitual lutein and zeaxanthin consumption prior to the study. MPOD did not correlate with serum or skin carotenoid measurements, suggesting unique tissue-based insights may emerge when treatment assignments are unmasked.", "population_specificity": "Subjects enrolled at the Moran Eye Center, likely with or at risk for age-related macular degeneration (AMD).", "effective_dosage": "10 mg lutein and 2 mg zeaxanthin per day.", "study_duration": "Annual visits, but exact intervention duration not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:23.441921+00:00"}
{"study_id": 74523, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "To determine whether lutein and zeaxanthin supplementation improves macular pigment and visual function in patients with early age-related macular degeneration (AMD).", "results_summary": "Lutein supplementation significantly increased macular pigment optical density (MPOD) and showed a dose-response effect. Improvements in contrast sensitivity and a trend toward better visual acuity were observed, correlating with MPOD increases.", "population_specificity": "Patients aged 50-79 with early AMD.", "effective_dosage": "10 mg/day lutein, 20 mg/day lutein, or 10 mg/day lutein plus 10 mg/day zeaxanthin.", "study_duration": "48 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:26.131929+00:00"}
{"study_id": 74524, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the efficacy and safety of lutein plus zeaxanthin (L+Z) in reducing the risk of progression to advanced age-related macular degeneration (AMD).", "results_summary": "The study assessed the effects of L+Z supplementation on AMD progression, but the abstract does not provide specific efficacy results for L+Z. The baseline characteristics and study design are detailed, but outcome data are not included.", "population_specificity": "Persons aged 50 to 85 with bilateral intermediate AMD or advanced AMD in one eye.", "effective_dosage": "10 mg lutein plus 2 mg zeaxanthin daily.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:27.099496+00:00"}
{"study_id": 74527, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to examine whether antioxidant supplements, including lutein, prevent the development of age-related macular degeneration (AMD).", "results_summary": "The study found no evidence regarding lutein's effectiveness in preventing AMD, as it primarily focused on vitamin E and beta-carotene. The authors noted a lack of data on other antioxidants like lutein.", "population_specificity": "62,520 people from Australia, Finland, and the USA.", "effective_dosage": "Not specified for lutein.", "study_duration": "Not specified for lutein.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:28.069110+00:00"}
{"study_id": 74525, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 85, "study_goal": "To examine the effects of lutein and zeaxanthin supplementation on retinal function in patients with early age-related macular degeneration (AMD).", "results_summary": "Lutein and zeaxanthin supplementation improved retinal function in early AMD patients, particularly in the central retina, with increases in N1P1 response densities and macular pigment optical densities (MPODs). No significant changes were observed in peripheral retinal function or peak latencies.", "population_specificity": "Patients with early AMD (n=108) and age-matched controls without AMD (n=36).", "effective_dosage": "10 mg/d lutein, 20 mg/d lutein, or 10 mg/d lutein plus 10 mg/d zeaxanthin.", "study_duration": "48 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:28.340889+00:00"}
{"study_id": 74526, "supplement_id": 1305, "safety_score": "90", "efficacy_score": 60, "quality_score": 85, "study_goal": "The researchers aimed to determine whether lutein/zeaxanthin supplementation could reduce the incidence of threshold ROP, NEC, and BPD in preterm infants.", "results_summary": "The study found no significant effect on threshold ROP, NEC, or BPD, but noted a 50% reduction in progression from early ROP stages to threshold ROP. No adverse effects were reported.", "population_specificity": "Preterm infants < 32(+6) weeks' gestational age.", "effective_dosage": "0.14 mg lutein + 0.0006 mg zeaxanthin daily.", "study_duration": "From birth till 36 weeks' corrected gestational age.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:28.749976+00:00"}
{"study_id": 74529, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to examine the nutrients and phytochemicals in pistachios, including lutein, and their potential health effects.", "results_summary": "Pistachios contain lutein and anthocyanins, contributing to their unique color. Among nuts, pistachios have high levels of xanthophyll carotenoids, including lutein, and may support heart-healthy lipid profiles, antioxidant activity, and glycemic control.", "population_specificity": "Subjects in weight-loss programs and general populations in cardiovascular and glycemic control studies.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:30.261733+00:00"}
{"study_id": 74530, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the potential cancer-preventive effects of carotenoids, including Lutein, and describe their possible mechanisms of action.", "results_summary": "The study found that Lutein, among other carotenoids, exhibits anti-carcinogenic activity in several tissues, suggesting potential preventive and/or therapeutic roles in cancer. However, high doses of \u03b2-carotene did not show chemopreventive effects in clinical trials, indicating variability in efficacy among carotenoids.", "population_specificity": "Not specified (general review of preclinical and clinical studies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:31.514914+00:00"}
{"study_id": 74528, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to determine whether lutein supplementation, alone or in combination with other macular carotenoids, could alter the spatial profile of macular pigment in subjects with atypical central peaks.", "results_summary": "Lutein alone (Group 1) showed no significant increase in macular pigment at any eccentricity. When combined with meso-zeaxanthin and zeaxanthin (Groups 2 and 3), there were significant increases in macular pigment at specific eccentricities, suggesting synergistic effects.", "population_specificity": "31 healthy subjects with atypical macular pigment spatial profiles (lacking a central peak).", "effective_dosage": "Group 1: 20 mg/day lutein, 2 mg/day zeaxanthin; Group 2: 10 mg/day meso-zeaxanthin, 10 mg/day lutein, 2 mg/day zeaxanthin; Group 3: 17 mg/day meso-zeaxanthin, 3 mg/day lutein, 2 mg/day zeaxanthin.", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:32.110229+00:00"}
{"study_id": 74531, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the short- and mid-term repeatability of macular pigment optical density (MPOD) measurements using reflectometry, particularly in monitoring lutein supplementation effects in AMD patients.", "results_summary": "Reflectometry demonstrated adequate short-term and mid-term repeatability for MPOD measurements, with coefficients of variation of 6.2% in healthy subjects and 8.0% in AMD patients. The technique was deemed suitable for clinical trials and monitoring MPOD changes in AMD patients.", "population_specificity": "Healthy young subjects (n=12) and AMD patients (n=37).", "effective_dosage": "Not specified in the abstract.", "study_duration": "5 consecutive days for healthy subjects; 6 months for AMD patients.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:35.830241+00:00"}
{"study_id": 74533, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the role of lutein, among other nutrients, in preventing or slowing the progression of age-related macular degeneration (AMD).", "results_summary": "High dietary intake of lutein was associated with a lower risk of prevalence and incidence in AMD, indicating a potential protective effect. However, the study did not provide specific efficacy data or statistical significance for lutein alone.", "population_specificity": "Individuals at risk of or diagnosed with age-related macular degeneration (AMD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:36.037630+00:00"}
{"study_id": 74534, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the neuroprotective effects of lutein and its underlying molecular mechanisms in animal models of vision-threatening diseases.", "results_summary": "Lutein reduced oxidative stress in the retina, inhibited downstream pathological signals, and prevented degradation of functional proteins (rhodopsin and synaptophysin), depletion of BDNF, and DNA damage, preserving visual function.", "population_specificity": "Animal models (mice) with innate retinal inflammation, diabetic retinopathy, and light-induced retinal degeneration.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:36.399378+00:00"}
{"study_id": 74532, "supplement_id": 1305, "safety_score": "85", "efficacy_score": 30, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of lutein- and zeaxanthin-rich foods and supplements on macular pigment levels and serological markers of endothelial activation, inflammation, and oxidation in healthy volunteers.", "results_summary": "The study found no significant effects on macular pigment levels or markers of endothelial activation, inflammation, or oxidation after 8 weeks of supplementation. However, changes in serum lutein and zeaxanthin were associated with changes in macular pigment levels in some participants, particularly those with initially low levels.", "population_specificity": "Healthy volunteers (n=52 in Study 1, n=75 in Study 2).", "effective_dosage": "Not specified (abstract mentions \"lutein- and zeaxanthin-rich foods\" and \"supplements containing lutein and zeaxanthin\" but does not provide exact dosages).", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:37.046501+00:00"}
{"study_id": 74535, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether regular consumption of gold kiwifruit, which contains lutein, affects plasma antioxidant levels and markers of oxidative stress, inflammation, and immune function in older individuals.", "results_summary": "Gold kiwifruit significantly increased plasma lutein/zeaxanthin concentrations and reduced plasma lipid peroxidation, but no changes were observed in innate immune function or inflammation markers.", "population_specificity": "Community-dwelling individuals aged 65 years or older.", "effective_dosage": "Equivalent of four kiwifruit daily.", "study_duration": "4 weeks per treatment, with a 4-week washout period.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:37.178846+00:00"}
{"study_id": 74536, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the impact of dietary interventions, including encapsulated fruit and vegetable juice concentrates (FVJCs), on serum lutein levels in ovarian cancer survivors.", "results_summary": "The study found that serum lutein levels were significantly increased in the FVJC group after 6 months (P<0.05), indicating a positive effect of the intervention on lutein bioavailability. No adverse effects related to lutein were reported.", "population_specificity": "Women diagnosed with stages II-IV ovarian cancer (mean age 53 years).", "effective_dosage": "Not specified (encapsulated fruit and vegetable juice concentrates were used).", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:39.098671+00:00"}
{"study_id": 74537, "supplement_id": 1305, "safety_score": "100", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate whether lutein supplementation, alone or combined with zeaxanthin, improves macular pigment optical density and visual function in patients with early atrophic macular degeneration.", "results_summary": "Lutein supplementation increased macular pigment optical density similarly to zeaxanthin but showed superior benefits in low-contrast visual acuity, contrast sensitivity function, and glare recovery, while zeaxanthin improved high-contrast visual acuity and shape discrimination. The combined group had less effective MPOD elevation, possibly due to competition between the carotenoids.", "population_specificity": "Older patients (mean age 74.9 years, predominantly male) with mild-to-moderate age-related macular degeneration.", "effective_dosage": "9 mg lutein (daily, as part of the intervention).", "study_duration": "1 year.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:41.295579+00:00"}
{"study_id": 74538, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether nutritional supplementation with lutein, zeaxanthin, astaxanthin, and other antioxidants improves visual acuity and visual function in patients with age-related macular degeneration (AMD).", "results_summary": "Patients treated with the supplement showed significantly better visual acuity, contrast sensitivity, and visual function scores compared to the non-treated group after 24 months, indicating stabilization and improvement in AMD symptoms.", "population_specificity": "145 patients with age-related macular degeneration (AMD).", "effective_dosage": "Lutein (10 mg), zeaxanthin (1 mg), astaxanthin (4 mg), plus other antioxidants/vitamins.", "study_duration": "2 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:41.380309+00:00"}
{"study_id": 74540, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the genetic factors influencing carotenoid metabolism, including Lutein, and their potential impact on absorption and tissue concentrations.", "results_summary": "The study identified several proteins and genetic variants associated with carotenoid metabolism, including Lutein, suggesting interindividual variability in absorption and tissue responses. Further research is needed to confirm these findings and explore personalized dietary guidelines.", "population_specificity": "General human population with genetic variability in carotenoid metabolism.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:43.778712+00:00"}
{"study_id": 74543, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers examined whether lutein, among other antioxidants, was inversely associated with cataract incidence in an elderly Indian population.", "results_summary": "Lutein showed a significant but weaker inverse association with cataract compared to vitamin C, though the effect was not consistently observed across all cataract types.", "population_specificity": "5,638 people aged \u226560 years from randomly sampled villages in north and south India.", "effective_dosage": "Not specified", "study_duration": "Not specified (cross-sectional study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:44.579717+00:00"}
{"study_id": 74541, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether lutein supplementation increases macular pigment optical density (MPOD) and improves visual acuity (VA) and macular function (MDLT) in patients with AMD.", "results_summary": "Lutein significantly increased MPOD by 27.9% but did not significantly improve MDLT or VA, though trends toward improvement were observed. A correlation was found between increased MPOD and improvements in MDLT and VA.", "population_specificity": "126 patients with AMD (AREDS stages 2, 3, and 4).", "effective_dosage": "Not specified in the abstract.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:44.936899+00:00"}
{"study_id": 74539, "supplement_id": 1305, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the serum and macular response to, and safety of supplementation with, lutein (L) in combination with meso-zeaxanthin (MZ) and zeaxanthin (Z).", "results_summary": "Supplementation significantly increased serum concentrations of lutein and zeaxanthin and central macular pigment optical density (MPOD) in the intervention group, with no adverse clinical implications noted.", "population_specificity": "44 healthy subjects", "effective_dosage": "5.9 mg lutein daily (combined with 10.6 mg MZ and 1.2 mg Z)", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:45.017752+00:00"}
{"study_id": 74542, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the potential roles of carotenoids, including Lutein, in preventing and treating various human diseases and health conditions.", "results_summary": "The abstract highlights that carotenoids from marine microalgae exhibit antioxidant, anti-inflammatory, and antitumoral properties, which may contribute to their effectiveness in addressing conditions like cancer, cardiovascular diseases, and neurological disorders. However, specific results for Lutein alone are not detailed.", "population_specificity": "Not specified (general human health applications).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:45.429316+00:00"}
{"study_id": 74546, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of lutein, among other antioxidants, in preventing cataract incidence and progression.", "results_summary": "Long-term use of lutein was associated with lower incidence and progression of cataracts, but prospective studies of vitamin supplementation showed little effect. The abstract suggests mixed evidence regarding lutein's efficacy in cataract prevention.", "population_specificity": "Not specified (general population implied, but not detailed).", "effective_dosage": "Not specified", "study_duration": "Long-term (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:49.719995+00:00"}
{"study_id": 74545, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 45, "study_goal": "The researchers aimed to assess knowledge about nutrition and eye health, including awareness of lutein's benefits, in an urban community health center population.", "results_summary": "Only 32.7% of respondents knew about the ocular benefits of lutein and other nutrients. Post-intervention, 75% reported changing eating habits, but the study did not measure lutein's direct efficacy.", "population_specificity": "Ethnically mixed, lower socioeconomic urban community health center patients, predominantly black (31.3%) and older than 55 years (26%).", "effective_dosage": "Not available", "study_duration": "1-month follow-up after intervention", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:49.993988+00:00"}
{"study_id": 74544, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the serum response of free lutein (fL) versus lutein esters (Le) during supplementation.", "results_summary": "The study found that free lutein resulted in significantly greater serum lutein levels per mg dose compared to lutein esters after 21 and 28 days, with a 17% higher AUC response. Baseline serum lutein levels and the form of lutein ingested influenced the response, while age, gender, BMI, and serum lipids did not.", "population_specificity": "72 volunteers aged 23-52 years with BMI 20-30 kg/m\u00b2 and baseline serum lutein <20 \u00b5g/dL.", "effective_dosage": "12.2 mg free lutein or 27 mg lutein esters (equivalent to 13.5 mg free lutein) daily.", "study_duration": "28 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:50.604016+00:00"}
{"study_id": 74547, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine whether weight loss affects serum concentrations of lutein (L) and zeaxanthin (Z) and macular pigment optical density (MPOD).", "results_summary": "The study found no significant changes in serum L and Z or MPOD over time, except for a decrease in dietary Z intake. However, body fat loss was positively correlated with increased serum L concentrations, suggesting fat acts as a reservoir for lutein.", "population_specificity": "104 overweight subjects", "effective_dosage": "Not specified", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:52.199205+00:00"}
{"study_id": 74548, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to identify genetic variants affecting blood and retina lutein concentrations and assess their role in modulating lutein levels.", "results_summary": "Six SNPs in four genes (ABCG8, BCMO1, CD36, and NPC1L1) explained significant variance in plasma lutein and macular pigment optical density (MPOD). Specific genetic variants in BCMO1 and CD36 were associated with differences in lutein concentrations.", "population_specificity": "29 healthy subjects in the comparative study and 622 subjects in the observational study.", "effective_dosage": "Not specified (lutein-rich supplement used, but exact dosage not mentioned).", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:53.693610+00:00"}
{"study_id": 74549, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the role of VEGF/VEGFR-2 in ovarian hyperstimulation syndrome (OHSS) and evaluate preventive approaches, including dopamine agonists, in high-risk patients.", "results_summary": "The study found that targeting VEGF/VEGFR-2 can effectively prevent OHSS, with dopamine agonists like cabergoline reducing moderate OHSS incidence from 44% to 20%. However, dopamine agonists were ineffective in pregnant patients.", "population_specificity": "High-risk oocyte donors (69 participants) and nonpregnant OHSS patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:53.869076+00:00"}
{"study_id": 74550, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to update current knowledge on the pharmacokinetic properties of herbal remedies, including Lutein, focusing on their metabolism, bioavailability, and disposition in humans.", "results_summary": "The study mentions that pharmacokinetic data for Lutein are available, but it does not provide specific findings on its effects or outcomes. The abstract highlights a general lack of data on the disposition and biological fate of many herbal remedies, including Lutein.", "population_specificity": "Humans (general, no specific subpopulation mentioned)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:54.124733+00:00"}
{"study_id": 74552, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the role of antioxidants, including Lutein, in preventing and treating ocular diseases, particularly cataracts.", "results_summary": "The study found that food-based antioxidants like Lutein appear beneficial for treating macular degeneration and cataracts, though supplements like vitamins A, C, E, and zinc may only prevent advanced macular degeneration in high-risk individuals.", "population_specificity": "Not specified (general review of literature)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:57.446281+00:00"}
{"study_id": 74553, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore the potential neuroprotective effects of lutein in reducing oxidative stress and free radical damage in preterm newborns.", "results_summary": "The abstract suggests that lutein, along with other interventions like melatonin and hypothermia, shows promise as a neuroprotectant by mitigating oxidative stress and its damaging effects in preterm newborns. However, specific results or data on lutein's efficacy are not detailed.", "population_specificity": "Preterm newborns at risk of oxidative stress and free radical damage.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:58.139029+00:00"}
{"study_id": 74555, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the impact of a Mediterranean diet, including lutein, on metabolic control and vascular risk in type 2 diabetes.", "results_summary": "The study found that plasma lutein/zeaxanthin levels increased by 25% on the Mediterranean diet, alongside improvements in glycemic control and diet quality. No adverse effects on weight were reported.", "population_specificity": "27 subjects (47-77 years) with well-controlled type 2 diabetes.", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:28:00.262160+00:00"}
{"study_id": 74556, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to explore the potential of Lutein and other phytonutrients as photoprotectants against UV-induced skin damage.", "results_summary": "The abstract suggests that Lutein, along with other carotenoids, shows promise as a photoprotectant, likely due to its antioxidant properties, but specific results for Lutein alone are not detailed.", "population_specificity": "Not specified (general reference to clinical, animal, and cell culture studies).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:28:02.671986+00:00"}
{"study_id": 74554, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether simvastatin therapy altered the plasma levels of lutein and other carotenoids, and if these changes were linked to lipid-lowering or anti-inflammatory effects.", "results_summary": "Simvastatin therapy reduced crude plasma levels of lutein, but after lipid adjustment, lutein levels significantly increased. Lutein was inversely correlated with inflammatory markers (CRP and IL-6), but changes in lutein status were not directly tied to changes in inflammation.", "population_specificity": "80 volunteers with mild to moderate hypercholesterolemia", "effective_dosage": "Not specified for lutein (simvastatin dosage: 40 mg daily)", "study_duration": "6 weeks", "interactions": "Simvastatin reduced plasma carotenoid levels, but lipid-adjusted levels increased. No other interactions mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:28:03.512600+00:00"}
{"study_id": 74557, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to determine whether lutein modulates multidrug resistance (MDR) in cancer cells expressing P-glycoprotein (P-gp) or MRP1 efflux pumps.", "results_summary": "Lutein induced moderate effects as a modulator of MDR in cancer cells, though it was less potent than other carotenoids like capsanthin and capsorubin. Its effects were studied by measuring rhodamine 123 uptake in human MDR1 gene-transfected mouse lymphoma cells (L1210) and human breast cancer cells (MDA-MB-231).", "population_specificity": "Human MDR1 gene-transfected mouse lymphoma cells (L1210) and human breast cancer cells (MDA-MB-231).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:28:03.541186+00:00"}
{"study_id": 74558, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 35, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the impact of lutein and zeaxanthin supplementation on macular pigment optical density (MPOD) and assess the reliability of heterochromatic flicker photometry for measuring MPOD.", "results_summary": "The study found that lutein supplementation (up to 20 mg/day) resulted in modest increases in MPOD (0.025 to 0.09), but these changes were often too small to be reliably detected by heterochromatic flicker photometry. The technique itself showed poor repeatability, making clinical monitoring of individual responses challenging.", "population_specificity": "Not specified (likely general or at-risk populations for macular health, but not detailed in the abstract).", "effective_dosage": "Up to 20 mg/day lutein.", "study_duration": "Six months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:28:04.205014+00:00"}
{"study_id": 74551, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of lutein as a preventive measure for age-related macular degeneration (AMD).", "results_summary": "The abstract mentions lutein as one of the nutritional supplements reviewed, but it concludes that only smoking cessation and the AREDS formula are proven effective preventive measures for AMD.", "population_specificity": "Individuals at risk for or with age-related macular degeneration (AMD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:28:05.166471+00:00"}
{"study_id": 74560, "supplement_id": 1305, "safety_score": "90", "efficacy_score": 50, "quality_score": 85, "study_goal": "The researchers aimed to compare the growth of infants fed lutein-fortified infant formula versus those fed unfortified formula.", "results_summary": "Infants in both groups showed appropriate growth with no significant differences in weight gain, head circumference, or length. Both formulas were well tolerated, and blood chemistry parameters were similar between groups.", "population_specificity": "Healthy term infants \u226414 days postnatal age.", "effective_dosage": "200 mcg/l lutein in fortified formula.", "study_duration": "16 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:28:06.572945+00:00"}
{"study_id": 74559, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of dietary supplementation, particularly lutein and zeaxanthin, on visual performance, age-related macular degeneration (AMD), and cataract risk.", "results_summary": "The study found that lutein and zeaxanthin supplementation improved contrast sensitivity and visual performance under glare conditions, reduced AMD occurrence, and decreased nuclear lens opacities, though results varied due to study limitations and unrecorded lifestyle factors.", "population_specificity": "Not specified (general population, likely including individuals at risk for AMD and cataracts).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:28:07.021598+00:00"}
{"study_id": 74561, "supplement_id": 1305, "safety_score": "85", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to measure plasma levels of lutein and zeaxanthin after oral lutein administration in preterm infants to assess absorption and potential effects.", "results_summary": "Lutein plasma levels increased by 13.5% at 6 h and 16.7% at 24 h post-administration, returning to baseline by 120 h. Zeaxanthin levels remained unchanged, indicating lutein is well absorbed in preterm infants.", "population_specificity": "Preterm infants (mean age 52 h of life, n=10).", "effective_dosage": "Single oral dose of 0.5 mg/kg.", "study_duration": "Measurements taken up to 120 h (5 days) post-administration.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:28:09.375962+00:00"}
{"study_id": 74563, "supplement_id": 1305, "safety_score": "90", "efficacy_score": 70, "quality_score": 85, "study_goal": "To determine if lutein supplementation slows visual function decline in patients with retinitis pigmentosa already receiving vitamin A.", "results_summary": "Lutein supplementation (12 mg/d) slowed midperipheral visual field loss in patients with retinitis pigmentosa taking vitamin A, particularly in those with higher serum lutein levels or increased macular pigment optical density. No significant toxic effects were observed.", "population_specificity": "Nonsmoking adults aged 18-60 with retinitis pigmentosa.", "effective_dosage": "12 mg of lutein daily.", "study_duration": "4 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:28:11.248659+00:00"}
{"study_id": 74562, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of GnRH agonist versus antagonist treatments on aromatase gene expression and related mechanisms in granulosa lutein cells.", "results_summary": "GnRH antagonist treatment significantly reduced serum and follicular-fluid oestradiol concentrations, aromatase activity, and mRNA aromatase expression compared to GnRH agonist treatment, with higher PKC activity observed in antagonist-treated cells.", "population_specificity": "50 women undergoing ovarian stimulation, divided into GnRH agonist (n=28) and antagonist (n=22) groups.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:28:11.313597+00:00"}
{"study_id": 74564, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize the current literature on lutein and zeaxanthin's bioactivity, focusing on their effects and mechanisms related to human eye health.", "results_summary": "The study found that lutein and zeaxanthin are concentrated in the retina and lens, suggesting specific roles in eye health. Epidemiological and clinical evidence supports their potential in preventing and treating eye diseases like age-related macular degeneration, cataracts, and retinitis pigmentosa, likely due to blue-light filtering and antioxidant properties.", "population_specificity": "General human population, with emphasis on ocular health.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:28:11.854193+00:00"}
{"study_id": 74566, "supplement_id": 1305, "safety_score": "90", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine whether consuming spinach or perilla preparations (5 mg lutein/day) increases carotenoid levels in plasma and affects oxidative stress markers.", "results_summary": "Lutein content significantly increased in plasma, with a more pronounced effect from perilla. Lipid peroxidation markers tended to decrease, but no change in plasma antioxidative capacity was observed.", "population_specificity": "12 healthy volunteers", "effective_dosage": "5 mg lutein/day", "study_duration": "10 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:28:13.129734+00:00"}
{"study_id": 74565, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the role of Lutein, along with other nutrients, in the prevention and progression of age-related macular degeneration (AMD).", "results_summary": "Observational studies suggest that high dietary intake of Lutein is associated with a lower risk of AMD, but only the AREDS trial demonstrated a 25% reduction in progression to advanced AMD with a specific supplement formulation. AREDS2 is prospectively evaluating Lutein's benefits further.", "population_specificity": "Older adults, particularly those with intermediate AMD or advanced AMD in one eye.", "effective_dosage": "Not specified in the abstract.", "study_duration": "5 years of follow-up in AREDS.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:28:13.253226+00:00"}
{"study_id": 74568, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether carbohydrate restriction and egg intake modulate circulating carotenoids, specifically lutein and zeaxanthin, and their effects on plasma apolipoproteins and lipoprotein distribution.", "results_summary": "The study found that dietary lutein and zeaxanthin increased during the intervention, but only subjects in the egg group (EGG) showed higher plasma concentrations of these carotenoids, which correlated with larger LDL particles. No adverse effects on lutein were reported.", "population_specificity": "Male subjects undergoing a weight loss intervention with carbohydrate restriction.", "effective_dosage": "Not specified (egg intake provided 640 mg additional cholesterol).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:28:16.138204+00:00"}
{"study_id": 74567, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to correlate angiotensin II receptor expression in granulosa-lutein cells with infertility diagnoses and IVF parameters.", "results_summary": "The study found a consistent 7:1 ratio between AT1 and AT2 receptors, with variations linked to age and infertility conditions. Low AngII receptor expression was associated with high-dose stimulation in poor ovarian reserve, and decreased AT1 receptor expression correlated with embryo fragmentation in women with no ovarian factor.", "population_specificity": "Seventy-three IVF patients, including those with no ovarian factor, poor ovarian reserve, endometriosis, and polycystic ovary syndrome.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:28:16.908583+00:00"}
{"study_id": 74569, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to study the expression of mRNA for KL1, KL2, FSHR, PAPP, and P450 in granulosa-lutein cells from IVF patients and its relationship with infertility diagnosis and IVF outcome.", "results_summary": "Infertile patients with healthy ovaries showed positive correlations among KL1, KL2, FSHR, PAPP, and P450 gene expression levels, while these correlations were disrupted in patients with ovarian disease. A normal pattern of gene expression and feedback was associated with pregnancy.", "population_specificity": "113 women undergoing IVF, including those with healthy ovaries and those with ovarian diseases like endometriosis and polycystic ovary syndrome.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:28:18.746053+00:00"}
{"study_id": 201116, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to compare the effectiveness and potential additive effects of dietary antioxidant supplements, including lutein, on various eye health parameters.", "results_summary": "The study found that lutein combinations (e.g., with zeaxanthin and fatty acids) significantly improved macular pigment optical density and contrast sensitivity, with the L + zeaxanthin + fatty acid combination ranking highly for these outcomes. However, the quality of evidence was noted as low due to indirectness and potential publication bias.", "population_specificity": "Not specified (abstract does not detail participant demographics).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:28:20.008564+00:00"}
{"study_id": 201117, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the effects of xanthophyll (including lutein) intake on visual outcomes, particularly in populations with eye diseases, through systematic review and meta-analysis.", "results_summary": "Xanthophyll intake improved macular pigment optical density (MPOD) and reduced photostress recovery time. Visual acuity improvement was observed specifically in patients with eye disease, and a positive correlation was found between MPOD and serum lutein levels.", "population_specificity": "Individuals with and without eye diseases", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:28:20.141816+00:00"}
{"study_id": 201115, "supplement_id": 1305, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the bioavailability of free versus esterified lutein and assess its impact on visual contrast threshold in healthy adults.", "results_summary": "Serum lutein levels increased significantly (2.4-fold) within 15 days and were maintained for two months, with no difference between free and ester forms. Visual contrast threshold improvements correlated with serum lutein levels, particularly under glare conditions, with stronger effects in older participants.", "population_specificity": "24 healthy adults (12 women, 12 men) aged 20-35 and 50-65 years.", "effective_dosage": "6 mg lutein/day from marigold extract (free or ester form).", "study_duration": "2 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:28:20.599335+00:00"}
{"study_id": 201119, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether lutein supplementation combined with a low-calorie diet could improve anthropometric indices, body composition, and metabolic parameters in obese middle-aged individuals.", "results_summary": "Lutein supplementation led to greater reductions in body fat percentage and preserved fat-free mass compared to placebo, with significant decreases in visceral fat and total cholesterol levels in the lutein group. No significant changes were observed in triglycerides, HDL-cholesterol, glucose homeostasis, or appetite sensations.", "population_specificity": "Obese middle-aged individuals (45-65 years)", "effective_dosage": "20 mg/d", "study_duration": "10 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:28:22.230549+00:00"}
{"study_id": 201118, "supplement_id": 1305, "safety_score": "85", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy and safety of lutein supplementation in patients with high myopia, focusing on macular pigment optical density (MPOD) and other ocular parameters.", "results_summary": "Lutein supplementation significantly increased MPOD in patients with axial length less than 28.25 mm but showed no significant differences in visual acuity, contrast sensitivity, or electroretinogram values between groups. The overall MPOD change was not significantly different between lutein and control groups.", "population_specificity": "Patients with high myopia (axial length > 26.00 mm).", "effective_dosage": "20 mg once daily.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:28:22.702959+00:00"}
